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Sickle cell disease (SCD) is a genetically inherited blood disorder characterized by a 
single point mutation that produces hemoglobin S within red blood cells (RBCs). When 
such RBCs are deoxygenated hemoglobin S polymerizes and causes the cells to take on 
a sickle shape and become more viscous and stiffer than normal RBCs. The hallmark of 
SCD is painful vaso-occlusive crises in which the flow of blood to parts of the body is 
obstructed. Today, millions of people suffer from SCD around the world and life 
expectancy of individuals with SCD is in the 40’s. We developed several techniques to 
facilitate and expedite experimental investigation of SCD and in general blood 
biomechanics. 
Vaso-occlusion is the result of interactions between blood cells and the endothelium. 
Atomic force microscopy (AFM) has been employed in single-molecule force 
spectroscopy (SMFM) and single-cell force spectroscopy (SCFS) assays to study these 
interactions. In order to process results from these assays quickly, we developed 
MATLAB-based custom software that expedited manual processing efforts from 1 to 2 
hours to 10 to 15 minutes per experiment. 
We explored microfluidic principles in order to further increase the throughput of the 
number of cells we can study. We have designed an experimental setup that implements 
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aspiration based assembly for microchannels which enables the use of most 
functionalization techniques, and a pressure controller that allows instant and precise 
changes in the microchannel flow. Utilizing this setup, we have quantified SS-RBC 
adhesion to the integrin αvβ3, a specific adhesion protein expressed on the endothelium 
which has been implicated in vaso-occlusion, and measured the shear modulus and 
viscosity of the SS-RBC membrane. 
We have designed a portable, swift, easy-to-use, small sample, and sterilization-free 
rheometer capable of measuring the viscosity of Non-Newtonian liquids. This rheometer 
can quickly measure the viscosity of body fluids such as whole blood and blood plasma, 
which has been hypothesized to be of value in the assessment of SCD. 
We explored expediting the development and review of simulations and three-
dimensional data. To this end, we have developed a virtual reality environment for 
interactive multiphysics simulation and data visualization utilizing modern head-mounted 
displays. 
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Chapter 1: Introduction  
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Sickle cell disease (SCD) is a genetically inherited blood disorder characterized by a 
single point mutation. This mutation results in the replacement of the adult hemoglobin in 
red blood cells by hemoglobin S (HbS). When red blood cells are deoxygenated HbS 
polymerizes and causes the cells to take on a sickle shape and a rigid structure. As a 
result, the hallmark of SCD is painful vaso-occlusive crises in which blood flow to parts of 
the body is obstructed [1]. Vaso-occlusion is the result of interactions between blood cells 
and the endothelium [2-4]. Today, millions of people suffer from sickle cell disease around 
the world and life expectancy of individuals with sickle cell disease is in the 40’s [5, 6]. 
There is currently no drug available for patients of sickle cell disease that targets the 
pathophysiology of the disease [7]. 
It has been shown that the adhesive behavior and viscoelastic response of sickle cell red 
blood cells (SS-RBCs) are important factors in vaso-occlusion [8]. SS-RBC adhesion to 
specific proteins, such as human integrin 𝛼𝑣𝛽3 and laminin, expressed on the endothelium 
has been implicated as part of the mechanism that triggers vaso-occlusive crises [2, 9-
12] . During a vaso-occlusive crisis adherent SS-RBCs in the vasculature obstruct other 
SS-RBCs due to their viscoelastic and mechanical properties [13, 14]. 
A number of experimental tools have been used to quantify SS-RBC specific adhesion to 
proteins expressed on the endothelium. To this end, atomic force microscopy (AFM) has 
been employed in single-molecule force spectroscopy (SMFM) and single-cell force 
spectroscopy (SCFS) assays [10, 15-17]. Briefly, an atomic force microscope is capable 
of measuring a wide range forces (5 pN to 106 pN) applied on a cantilever probe by 
recording the deflection of the cantilever [18, 19]. Through the use of a controlled vertical 
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displacement applied to the probe by piezoelectric actuators the technique can produce 
force-displacement signals during both the approach and the retraction of the probe 
toward a cell. When the cantilever probe is functionalized with a specific ligand, the bond 
strength of the ligand and its receptor can be measured on the retraction force-
displacement curve [17]. Significant data processing and additional experimentation was 
necessary of our publication using single-cell force spectroscopy studying the BCAM/Lu 
and laminin specific adhesion [16]. In particular, we reprocessed the entirety of the SMFS 
experimental data to ensure that each adhesion measurement represented specific 
binding with an RBC. We distinguished these sites from erroneous data points by 
identifying an effective spring constant of the adhesion complex and ensuring that we 
processed data in which this constant was less that 10 pn/nm. We measured this spring 
constant as the slope of the retraction curve after the cantilever retracted past the cell 
surface and before adhesion complex was broken. We also performed experiments to 
evaluate cell stiffness which was calculated by probing red blood cells (RBCs) with an 
AFM cantilever and curve fitting a theoretical model derived from the Hertz model to the 
force-displacement response curves. 
In order to process these results quickly, we developed MATLAB-based custom software 
that expedited manual processing efforts from 1 to 2 hours per experiment to 10 to 15 
minutes per experiment. The MATLAB-based data processing tools developed as part of 
this project were later published as FRAME, the Force Review Automation Environment 
[22]. 
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We sought to further increase the throughput of the number of cells we could reasonably 
study and explored microfluidic principles to accomplish this. Typical microfluidic assays, 
which aim at quantifying mechanical properties of sickle cell red blood cells (SS-RBCs), 
suffer from a number of drawbacks in functionalization and flow control. Specifically, 
physical adsorption functionalization techniques produce inconsistent functional surfaces, 
and common volumetric flow pumps cannot be used to adjust the flow inside 
microchannels with minimal delay. We have designed an experimental setup that 
alleviates these complications by implementing aspiration for microchannel assembly that 
enables the use of most functionalization techniques and a pressure controller that allows 
instant and precise changes in the microchannel flow. Utilizing this setup, we have 
quantified SS-RBC adhesion to the integrin αvβ3, a specific adhesion protein expressed 
on the endothelium, as well as measured the shear modulus and viscosity of the SS-RBC 
plasma membrane. 
We explored expediting the development and review of simulations and three dimensional 
data in sickle cell disease. To this end, we employed virtual reality. The recent commercial 
success of virtual reality based on head-mounted display (HMD) technology has the 
potential to fundamentally enhance the way we create, review, and interact with 
simulations and three-dimensional data. Representation of such data and simulations in 
virtual reality grants users the ability to explore them intuitively and personally. To this 
end, we have developed a virtual reality environment for interactive multiphysics 
simulation and data visualization. This environment integrates the visual fidelity, coding 
standards, and affordability of modern HMDs with (1) manual and immersive three-
dimensional particle steering during simulation run-time and with (2) undistorted 
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volumetric rendering of static volumetric maps such as those produced by confocal 
microscopy. This method of visualization provides a deeper understanding of such data 
structures than previously explored methods, such as three dimensional anaglyph 
stereoscopy. 
We encountered the hypothesis that leg ulcerations and vaso-occlusive episodes in sickle 
cell disease were related to whole blood viscosity. Unfortunately, current blood viscosity 
measurement techniques are inadequate for large scale measurements. In particular, 
commercially available rheometers are typically cumbersome, slow, necessitate constant 
cleaning, and are priced in the tens of thousands of dollars at the most affordable. Such 
devices are particularly inconvenient for clinical laboratory and point-of-care use because 
of the large amount of fluid needed and because of sterilization requirements before and 
after use.  
Engineering, whether mechanical or not, is defined first and foremost by its key 
constituent: synthesis. It is in this spirit of synthesis that we designed a portable, swift, 
easy-to-use, small sample, sterilization-free, and cost-effective rheometer capable of 
measuring the viscosity of both Newtonian and Non-Newtonian liquids. This rheometer 
can quickly measure the viscosity of body fluids such as whole blood, blood plasma and 
urine which have been found to be important in cardiovascular health assessment and 
cognitive function evaluation as well as an important marker in certain diseases, such as 
Alzheimer’s disease, dementia, myeloma, rheumatoid arthritis, and Waldenström’s 
Macroglobulinemia as well as explore the aforementioned hypothesis in sickle cell 
disease. This device will also quantify the viscosity of liquids such as inks, bioprinting 
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inks, and oils, where viscosity is crucial during formulation, quality assurance, and, in the 
case of bioprinting inks, in regular use. An assembly based on this technique could 
produce a device that is fast (1-5 minutes), portable, easy to use, requires only a drop of 
the liquid (no more than 50 microliters), and does not need regular cleaning and 
sterilization thanks to the use of a disposable microchannel cartridge.  
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Chapter 2: FRAME (Force Review Automation Environment): 
MATLAB-based AFM data processor  
  
 8 
 
2.1 Introduction 
An atomic force microscope (AFM) is capable of measuring a wide range forces (5 pN to 106 pN) 
applied on a cantilever probe by recording the deflection of the cantilever [27, 62]. Controlled 
vertical displacement is applied to the probe by piezoelectric actuators in order to produce force-
displacement curves. Atomic force microscopy has several applications. In particular, resultant 
force-displacement curves have been used to measure the elastic modulus of biological samples 
[63] and the unbinding force between specific receptor-ligand bonds [27]. Manually processing 
these data requires researchers to separately review each measurement. This is very time 
consuming and susceptible to user error or bias. Few free software applications for automatic 
processing of AFM force measurements have been developed, and only two such programs have 
seen some use [64, 65]. OpenFovea processes unbinding measurements by curve-fitting either 
the Worm Like Chain (WLC) or the Freely Jointed Chain (FJC) models in order to identify unbinding 
events, while Hooke uses a fuzzy logic algorithm to identify unbinding events based on 
conformity with specific, pre-defined, characteristics. However, in AFM experiments that probe 
cellular surfaces directly, and in single cell force spectroscopy (SCFS) experiments, both 
aforementioned methods cannot be implemented since cellular surface deformation and 
multiple simultaneous ligand-receptor bonds alter the force-displacement curve shape [16, 53]. 
As a result, most AFM data are still manually processed, and no clear standard has emerged in 
the automated processing of both Young’s moduli and ligand-receptor unbinding measurements. 
We have created an open-source software application based on MATLAB, the force review 
automation environment or FRAME, to greatly increase the speed at which AFM data are  
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Figure 2-1. Comparison of data processed manually and using FRAME. (a) FRAME 
displays the contact fit (dashed black line) used to compute a sample’s Young’s 
modulus, the contact point (black circle) and the end of fit point (green circle) based on 
the force-displacement curve (red and blue line plots). (b) Box-whisker plots showing 
the results of Young’s modulus measurements on Human Embryonic Kidney 
(HEK293T) cells as processed from the same data set manually and using FRAME. 
The two results do not pass the test of significant difference (nonparametric Mann-
Whitney test, p>0.8). (c) Histograms showing the results of Young’s modulus 
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processed. FRAME is intuitive and easy to operate, even for the novice MATLAB user. It features 
a number of algorithms to streamline automated processing and a graphic user interface (GUI) 
to expedite manual processing and review of the data. Even if FRAME is only used in manual 
mode it can greatly accelerate data processing, especially for large sets of data. The results can 
be displayed in FRAME with MATLAB plotting tools, as well as exported as a Microsoft Excel file, 
for further statistical analysis. FRAME, the User Manual, and a demonstration video can be found 
online at the Cellular Mechanics Laboratory webpage 
(http://www.engr.uconn.edu/~gelyko/frame.html). FRAME is shared both as a Windows 
executable and as MATLAB code under the open-source BSD license. 
2.2 Methods 
FRAME can be used to compute Young's moduli and ligand-receptor unbinding forces. 
In particular, the Hertz contact model for spherical and pyramid shape cantilever tip has 
been implemented [66, 67]. Manual processing of data produced in a contact experiment 
requires the user to identify, on the force-displacement curve, the point where the 
cantilever tip comes in contact with the sample's surface. FRAME uses a least-squares 
minimization for the curve-fit of the Hertz contact model to identify both the Young’s 
measurements on HEK293T cells as processed from the same data set manually and 
using FRAME. (d) FRAME detection of an unbinding event (purple line plot noted by 
arrow) between αvβ3 and ICAM4 receptor expressed on the surface of a red blood cell 
(SS-RBC) from a patient with sickle cell disease (SCD) and an approximation of the 
curve behavior before the unbinding event (teal line plot) on a force-displacement curve 
(red and blue line plots). (e) Box-whisker plots of unbinding forces between αvβ3 
attached on a cantilever tip and ICAM4 receptor expressed on the surface of a SS-
RBC. When processed manually and using FRAME, the results show no significant 
difference (nonparametric Mann-Whitney test, p>0.84). (f) Histograms of unbinding 
forces between αvβ3 attached on a cantilever tip and ICAM4 receptor expressed on the 
surface of a SS-RBC as processed manually and using FRAME. 
 11 
 
modulus of the sample and the contact point on the curve. Before any force-displacement 
curve is fit with a contact model, it is first “flattened,” a process in which the curve’s force 
response before contact with the sample is defined to have an average force value of 
zero. In order to curve-fit the extension portion of force-displacement curves to the contact 
model and locate the contact point, FRAME effectively uses a least-squares minimization 
of the following expression: 𝐹(𝑧) = 𝑔(𝑧 − 𝑧1) ∗ [𝐻(𝑧 − 𝑧1) − 𝐻(𝑧 − 𝑧2)]. In this expression 
𝑧 is the vertical displacement, 𝐹(𝑧) is the force detected by the cantilever, 𝐻 is the 
Heaviside function, 𝑔(𝑧) represents the contact model, 𝑧1 is the contact point and a design 
variable, and 𝑧2 is the end the curve-fit range which can be either defined by the user or 
be a design variable. The initial conditions for the minimization are determined from the 
flattening process (see supplementary information). Other contact models can be easily 
implemented by the user through a simple guided modification of the MATLAB script. The 
step by step instructions for using custom contact models can be found in the user 
manual. The quality of the curve-fit, based on the root-mean-squared of the curve-fit 
residuals, can also be employed to ignore low quality curves from data sets. FRAME also 
provides users with the tools to manually identify the contact point and the curve-fit range 
on individual curves while retaining automated processing functionality on all others. 
In addition, FRAME provides users with a set of algorithms to detect and quantify ligand-
receptor unbinding events based on a number of user provided parameters. Potential 
unbinding events are selected by the algorithms based on force thresholds provided by 
the user. The unbinding event detection algorithms verify that high amplitude noise is not 
misinterpreted as an unbinding event by confirming that the abrupt curve shift at the 
location of a possible unbinding event is permanent. FRAME can fit the curve before an 
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unbinding event to the WLC model and produce the persistence and contour lengths 
associated with this event. Because the software treats each unbinding event on an 
individual basis and because users may alter many relevant parameters for unbinding 
event detection, these algorithms are applicable to any force range. FRAME is equipped 
with several functions and a user friendly GUI that allow users to very quickly review 
preliminary results and modify parameters based on a few representative curves per set 
of data in order to assure consistent performance. Users also have access to tools that 
allow them to manually select unbinding events on individual curves while retaining 
automated processing functionality on all others. 
2.3 Results 
We compared results derived from manual and automatic processing of data collected in 
receptor-ligand unbinding and in elasticity experiments.  
2.3.1 Young’s Modulus Measurements 
Measurements of the Young’s modulus of four Human Embryonic Kidney (HEK293T) 
cells were automatically and manually processed (see Supplementary information). The 
parameters for FRAME automated processing were chosen with regard to representative 
curves and the set of data was automatically processed using these parameters. We did 
not observe a statistically significant difference between manually processed and FRAME 
processed results (see Figure 2-1b). Based on these findings it is confirmed that the 
proposed automated method generates results consistent with manually processed 
results. 
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Figure 2-2. The FRAME graphical user interface (GUI) during typical use for unbinding 
event detection. All options, parameters, tools, and plots of force-displacement curves 
are available on one window. 
2.3.2 Unbinding Events Measurements 
Unbinding-force measurements were taken between the ICAM4 receptor expressed on 
the surface of a sickle human red blood cell (SS-RBCs) and a probe functionalized with 
the integrin αvβ3 and manually processed (see Supplementary information). The 
parameters for FRAME automated unbinding event detection were set with regards to 
representative curves. The curves were automatically processed using these parameters. 
We did not observe a statistically significant difference between manually processed and 
automatically processed results (see Figure 2-1e) 
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2.4 Discussion 
FRAME offers a directly applicable array of modifiable tools to AFM users for expediting 
data processing. The software processes AFM data extremely quickly compared to the 
time required for manual processing. 1024 curves are processed in less than one minute 
for unbinding events and in less than five minutes for Young's modulus measurements in 
a work station with an Intel® Core™ 2 Duo CPU at 3.00 GHz and 8.00 GB of installed 
memory (RAM). FRAME also provides convenient manual processing tools that are 
integrated with automated processing. The GUI is intuitive and easy to use, requiring little 
to no user training. FRAME can automatically import force-displacement curves from 
AFMs by Asylum Research (.ibw files). Users of other brands of AFMs can import force-
displacement measurements formatted as delimited text files into FRAME following 
instructions in the User's Manual. 
2.5 Supplementary Information 
2.5.1 Cell Culture and Preparation 
Human Embryonic Kidney (HEK293T) cells were plated on poly-L-lysine coated glass 
bottom petri dishes in solution containing Dulbecco’s Modified Eagle media, 10% fetal 
bovine serum, and 1% Penicillin-Streptomycin.  
Heparin-anticoagulated venous blood was drawn from patients with sickle cell disease 
with the approval of the Institutional Review Boards of the UCONN Health Center and 
UCONN-Storrs. The whole blood, containing sickle cell human red blood cells (SS-
RBCs), was centrifuged at 500 g for 10 minutes at 4°C to isolate the cells and discard the 
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buffy coat and plasma. The SS-RBCs were washed three times with Alsever’s solution 
and stored in Alsever’s solution. SS-RBCs were immobilized by incubation for 10 minutes 
at 37°C on a poly-L-lysine coated glass bottom petri dish. Excess and unattached SS-
RBCs were washed away by rinsing. 
 
2.5.2 Probe Functionalization 
Silicon nitride cantilever probes (Bruker Probes, Camarillo, CA) were silanized with 2% 
v/v 3-aminopropyltriethoxysilane in acetone (10 minutes). Following silanization, the 
 
Supplementary Figure 2-S1. The effects of varying the slope ratio 𝒃 in the FRAME 
stiffness algorithm on two hundred curves. (a) The detected contact point on individual 
curves does no change more than 60nm from the average measurement as the slope 
ratio 𝒃 is varied. (b) The corresponding Young’s Moduli are not significantly different 
from one another as the slope ratio 𝒃 is varied (nonparametric Kruskal-Wallis test, 
p>0.8). 
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probes were rinsed with deionized water and immersed in glutaraldehyde (0.5%, 30 
minutes). The probes were then rinsed with deionized water and incubated in αvβ3 
solution (100 μg/mL, 30 minutes). The probes were rinsed again and incubated in BSA 
(100 μg/mL, 5 minutes) in order to block any remaining aldehyde groups. Probes were 
stored at 4°C in phosphate buffered saline (PBS) and used within 48 hours. 
2.5.3 AFM methods 
For atomic force microscope (AFM) procedures in stiffness measurements of HEK293T 
cell please refer to the relevant sections of [68]. 
For AFM procedures in unbinding event measurements of SS-RBCs please refer to the 
relevant sections of [69]. 
2.5.4 Stiffness Curve Fitting Methods 
Before curve-fitting is performed, each force-displacement curve is “flattened,” a process 
in which the non-contact portion of the curve is set to have an average force response of 
zero based on a linear regression in that portion of the curve. FRAME flattens the curve 
in two steps. In the first step, it roughly guesses the contact point based on the location 
of the relative decline in slope from the end of the approach curve (left side of the red 
curve shown in Figure 2-1a). The search algorithm determines, starting from the leftmost 
end, the point where the local slope of the approach curve is 𝑏 = 50% lower than the 
slope at the leftmost end of the approach curve. We note that a value of 𝑏 between 10% 
and 90% produces consistent final results (see Supplementary Figure 2-S1). FRAME 
then applies a linear regression to the data from the start (rightmost end) of the approach 
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curve to this estimated point, and the curve is flattened based on the results of this linear 
regression. In the second step, the resultant curve from the first step is used to obtain 
bounds and initial conditions that are inserted in a least-squares-based curve-fit algorithm 
to produce the final flattened curve as explained next.  
Specifically, FRAME minimizes the following equation: 
𝐹(𝑧) = 𝑓1(𝑧) + 𝑓2(𝑧) + 𝑓3(𝑧) 
𝑓1(𝑧) = 𝑘1𝑧 + 𝑘2 
𝑓2(𝑧) = 𝑔(𝑧 − 𝑧1) ∗ [𝐻(𝑧 − 𝑧1) − 𝐻(𝑧 − 𝑧2)] 
𝑓3(𝑧) = [𝑘4(𝑧 − 𝑧2) + 𝑔(𝑧2 − 𝑧1)] ∗ [𝐻(𝑧 − 𝑧2)], 
where 𝑧 is the vertical displacement, 𝐹(𝑧) is force, 𝐻 is the Heaviside function, 𝑔(𝑧) 
represents the contact model (Hertz rigid pyramid and Hertz spherical models are 
included in FRAME)model, and 𝑘1, 𝑘2, 𝑘4, 𝑧1, and 𝑧2 are the design variables. In addition, 
there is another design variable, 𝑘3 which is part of the contact model. Function 𝑓1 is 
determined by the linear behavior of the force-displacement curve before contact. 
Function 𝑓2 defines the contact model and its active domain. Finally function 𝑓3 is 
determined by the curve behavior after the contact model range (beyond 𝑧2). The contact 
model must be used in the flattening process because it affects the determination of the 
non-contact domain where the curve must be flat. The contact point is defined as 𝑧1, while 
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𝑧2 defines the end of contact model domain. Users have the option of setting 𝑧2 to an 
exact value relative to 𝑧1 or to set it as a design variable with defined bounds. The exact 
expression of the function 𝑔(𝑧) depends on the geometry of the specific probe's tip. In 
particular, for a rigid pyramid tip 𝑔(𝑧) = 𝑘3𝑧
2, where 𝑘3 =
3
4
𝐸 tan(𝜃)
(1−𝑣2)
, 𝐸 is the sample’s 
Young’s modulus, 𝜃 is the angle between the sample and the side of the pyramid, and 𝑣 
is the sample’s Poisson’s ratio. For a rigid spherical tip 𝑔(𝑧) = 𝑘3𝑧
3/2 , where 𝑘3 =
4
3
𝐸
(1−𝑣2)
 𝑅0.5, 𝐸 is the sample’s Young’s modulus, 𝑣 is the sample’s Poisson’s ratio, and 𝑅 
is the radius of the spherical tip. The contact point is defined as 𝑧1, while 𝑧2 defines the 
end of contact model domain. Users have the option of setting 𝑧2 to an exact value relative 
to 𝑧1 or to set it as a design variable. To finalize flattening the function 𝑓1(𝑧) is subtracted 
from the curve. To obtain the contact point and the stiffness of the sample after flattening, 
the minimization described above is repeated. We note that since flattening has already 
been performed the value of the new 𝑘1 is approximately zero. 
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Chapter 3: Atomic Force Microscopy in Single-Molecule Force 
Spectroscopy and Single-Cell Force Spectroscopy 
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3.1 Introduction 
Although red blood cells (RBCs) are considered to be relatively inactive due to their lack 
of a nucleus and organelles, they express surface adhesion receptors [17]. Many of these 
receptors mediate cell-cell interactions, or adhesion, on healthy and pathological RBCs. 
Knowledge of cytoadhesion is necessary to understand normal physiology, disease 
pathophysiology, and cellular-level effects of pharmacotherapies. Atomic force 
microscopy (AFM) [18] has introduced a wide range of approaches for measurements of 
biological samples under physiological conditions [15, 19-27]. Here, we present single-
cell force spectroscopy (SCFS) as a tool [28-31] for the quantitative study of RBC 
adhesion while maintaining surface receptors in their native state. The technique is 
performed by measuring the adhesion between a single RBC attached to an AFM 
cantilever and a surface coated with purified proteins. 
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AFM studies of RBC adhesion have been utilized to provide quantitative evidence of 
changes in surface receptor distribution and values for unbinding forces with specific 
ligands [15, 26]. A technique known as single-molecule force spectroscopy (SMFS) 
measures the unbinding force, or detachment force, between a ligand on the AFM tip and 
its corresponding receptor on the cell membrane with piconewton sensitivity [15, 22, 25, 
27, 32-34]. SMFS operates by collecting a set of force-distance curves of the approach-
retract cycle between the functionalized tip and the cell surface. Specifically, the retraction 
curve gives the detachment force. This technique allows for (i) quantifying the unbinding 
force of specific receptor-ligand bonds, (ii) mapping the distribution and (iii) calculating 
the density of active receptors on cellular surfaces with high resolution [35-39]. While 
SMFS is a powerful technique to study RBC adhesion at the single-molecule level, it 
cannot provide the overall adhesion of a cell to a substrate or to another cell. Further, it 
is unknown how SMFS measurements compare to whole cell measurements. 
To overcome these limitations, SCFS assays were developed [28-30, 40-42]. In SCFS, a 
RBC attached to an AFM cantilever is positioned above a functionalized substrate or 
another living cell. SCFS records force-distance curves of an approach/retract cycle 
between the RBC probe and the functionalized substrate or cell. The RBC is lowered onto 
the substrate/cell until a preset contact force is reached, and then held stationary for a 
defined time. Subsequently, the cell is withdrawn at a constant speed and bonds between 
the cell and substrate/cell break until separation. The detachment force is characterized 
as the force required to fully disengage the RBC from the functionalized substrate. While 
this in vitro assay can provide important details regarding RBC binding to laminin, it should 
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be noted that in vivo RBCs may attach to a deformable layer of endothelial cells or interact 
with other glycoproteins. 
Here, we established the technique of SCFS as a method to probe RBC adhesion, 
specifically with subendothelial laminin proteins. We found a correlation between SMFS 
measurements and SCFS measurements. We also showed that SCFS can detect 
significant changes in the adhesive response of RBCs to modulation of the cyclic 
adenosine monophosphate (cAMP) pathway. Based on these measurements, we 
identified variability in the RBC adhesion force to laminin amongst the human subjects, 
suggesting that RBCs maintain diverse intracellular levels of tonic protein kinase A (PKA).  
3.2 Methods 
3.2.1 Human subjects, blood samples, and blood preparation 
Healthy volunteers at least 18 years old were eligible to participate in this study if they did 
not have a blood disorder or hemoglobinopathy, confirmed by screening blood samples 
via complete blood count and hemoglobin electrophoresis. This study was approved by 
the Institutional Review Boards of the UCONN Health Center and UCONN-Storrs. 
Experiments were performed using fresh-drawn, heparin-anticoagulated venous blood. 
Blood was centrifuged at 500g for 10min at 4°C to isolate the RBCs. The buffy coat and 
plasma were aspirated and discarded. RBCs were then washed 3x with Alsever’s 
solution. 
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3.2.2 Reagents 
Alsever’s solution, laminin, glutaraldehyde, biotinamido-caproyl-labeled bovine serum 
albumin (biotin-BSA), streptavidin, biotinylated-concanavalin A (ConA), 3-
aminopropyltriethoxysilane (APTES), forskolin (Coleus forskohli), KT-5720, epinephrine, 
BSA, were purchased from Sigma Aldrich (St. Louis, MO). BCAM protein was obtained 
from Novus Biologicals (Littleton, CO). 
3.2.3 Surface coating with laminin 
Glass petri dishes (Ted Pella, Redding, CA) were divided using a hydrophobic PAP pen 
(Sigma Aldrich, St. Louis, MO) enabling us to separate RBCs from the laminin surface 
(Figure 3-1a). Half of the glass surface was silanized with 2% APTES for 10min, rinsed 
with deionized (DI) water, treated with 0.5% glutaraldehyde for 30min, rinsed, incubated 
in laminin solution for 30min, rinsed, and incubated in BSA (100μg/mL) for 5min. 
3.2.4 Cantilever preparation 
Tipless silicon nitride AFM cantilevers (NanoWorld, Neuchâtel, Switzerland) were soaked 
in acetone for 5min, UV irradiated for 15min, incubated overnight in 0.5mg/ml biotin-BSA 
at 37°C,  rinsed and treated with 1% glutaraldehyde for 30s, rinsed, incubated in 0.5mg/ml 
streptavidin for 10min, rinsed, and incubated in 0.5mg/ml biotinylated Con A for 10min at 
25°C. 
Pyramid-tipped silicon nitride cantilevers (Bruker Probes, Camarillo, CA) for single-
molecule experiments were functionalized with BCAM protein as follows. Cantilevers 
were silanized with 2% APTES for 10min, rinsed with DI water, immersed in 0.5% 
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glutaraldehyde for 30min, rinsed, incubated in BCAM solution (100μg/mL) for 30min, 
rinsed, and incubated in BSA (100μg/mL) for 5min.  
3.2.5 Cell capture and experimental setup 
Cells were allowed to bind weakly to the non-functionalized region of the glass substrate 
via 10min incubation at 37°C followed by rinsing with Alsever’s solution, thus allowing for 
cantilever engagement with a chosen RBC. Single cells were captured by positioning the 
ConA-functionalized cantilever above the cell center (Figure 3-1a) and gently lowering 
onto the cell for ~30s with a contact force of 1nN near the end of the probe (Figure 3-1c) 
to prevent the cantilever surface from interacting with the laminin substrate. The cell was 
lifted from the surface and allowed to establish firm adhesion to the cantilever before  
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relocation to the laminin-functionalized region of the dish. 
 
Figure 3-1 Measurement of red blood cell adhesion to subendothelial matrix laminin 
using single-cell force spectroscopy. (a) The apex of a tipless ConA-functionalized AFM 
cantilever is positioned above a RBC. It is then gently pushed (~1 nN) for 30s onto the 
cell. The cantilever-bound RBC is separated from the substrate and allowed to establish 
firm adhesion to the cantilever for 1 min. The cantilever is then slowly moved to the 
functionalized segment of the petri dish to perform adhesion measurements. (b) 
Representative force-distance curves obtained from experiments for an RBC probing a 
laminin substrate. The measured detachment forces are 0.64nN in the first curve which 
shows a single rupture and 1.06nN in the second curve which shows multiple rupture 
events. (c) Optical microscopy image showing a human RBC attached to the apex of a 
ConA-functionalized cantilever. 
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3.2.6 AFM setup 
Experiments were conducted using the MFP-3D-BIO AFM (Asylum Research, Santa 
Barbara, CA) mounted on an inverted optical microscope (Zeiss Axiovert A1). For SCFS, 
the nominal spring constant of the employed cantilever was 80mN/m. For SMFS, the 
nominal spring constant of the employed cantilever was 30mN/m. The effective spring 
constant was obtained via a thermal noise-based method and used in all calculations [43]. 
All experiments were performed in Alsever’s solution at 37°C, and biochemical 
modulators were added 30min prior to experiments. For each assay, 5 RBCs were tested 
from each subject’s blood. Values reporting “N=” denote the number of subjects per 
condition and “n=” denote the total number of tested cells. 
Each SMFS measuring session involved probing a 1µmx1µm region with a lateral 
resolution of ~31.2nm. For substrate measurements, 3 areas of a functionalized substrate 
were chosen at random and probed. For RBC measurements, one 1µmx1µm region was 
recorded per RBC. Experiments were performed at a retraction speed of 800nm/s. Only 
measurements with a single break between laminin on the cantilever tip and BCAM/Lu 
on the laminin substrate or RBC surface were processed.  
Each SCFS measuring session involved testing a single RBC probe attached to a 
previously calibrated cantilever for 100 approach/retraction cycles on one section of a 
laminin-functionalized glass substrate. As monitored by optical microscopy, the captured 
cells rarely detached from the cantilever during pulling. Tests were performed with a 
trigger force of 500pN with a contact time of 0.1s (unless noted), and the cantilever was 
retracted at 800nm/s until the RBC completely detached from the laminin substrate. 
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Force-distance curves were used to determine the detachment force of the RBC from the 
substrate. A detachment force is defined as the maximum downward force associated 
with the force-distance curve [28]. The median effective spring constant for the cantilever-
RBC-laminin adhesion complex was ~4.6pN/nm. We note that during the course of testing 
each specific cell the median effective spring constant did not change, meaning that the 
mechanical properties of the RBC membrane did not change during this experiment. 
Representative curves are shown in Figure 3-1b. Further, while we could have also 
computed the work of detachment [31], we preferred not to do so in order to properly 
compare the SCFS measurements with SMFS measurements. 
For both assays, we found that at 800nm/s hydrodynamic forces do not significantly affect 
detachment measurements (Supplementary Material). We considered only 
measurements for which the effective spring constant of the adhesion complex was less 
than 10pN/nm with a median value of ~4.6pN/nm. 
3.2.7 Statistical methods 
Values for detachment forces are reported using box-and-whisker plots and frequency 
distributions. In the frequency distributions reported for SCFS experiments, each bin 
contains the number of detachment forces with values within the bin’s range divided by 
the total number of approach/retraction cycles. For SMFS, frequency (%) is defined as 
the total number of all non-zero force points divided by the total number of sampled sites 
for each experimental condition.  
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3.3 Results And Discussion 
3.3.1 Surface density of laminin for functionalized substrates 
To obtain the experimental parameters used in our SCFS assay, we first determined the 
appropriate solution concentration of laminin to be used for substrate functionalization. 
SMFS experiments were performed using a BCAM-functionalized probe against 
substrates prepared with various solution concentrations of laminin (1µg/ml, 5µg/ml, 
10µg/ml, 25µg/ml, 50µg/ml, 100µg/ml). For each substrate, 1024 measurements were 
recorded in three different 1µmx1µm areas yielding a total of 3072 measurements for 
each laminin solution concentration.  
The detachment force of BCAM with laminin was nearly constant across all solution 
concentrations (Figure 3-2b). Interestingly, this detachment force was larger than what 
we previously measured for the inverse interaction between BCAM on the RBC and 
laminin on the AFM probe using SMFS [15, 26]. We conjecture that more BCAM proteins 
attached to the AFM tip make contact with multiple laminin proteins on the substrate since 
we recorded multiple distinct rupture forces. A representative curve is shown in Figure 3-
1b. BCAM proteins are approximately 6nm [44, 45], whereas laminin is a cruciform 
structure with arms of lengths ranging between 40nm and 80nm [46]. Upon functionalizing 
a substrate with BCAM and measuring the detachment force using a laminin-
functionalized probe, we confirmed that the median unbinding force is 41.4pN, in 
agreement with previous measurements (Figure 3-2a).  
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Figure 3-2 Determination of laminin solution concentration to be employed in SCFS assay. (a) 
Frequency distributions obtained from SMFS experiments of measured detachment forces 
between (i) a substrate coated with laminin (50 µg/ml) and a BCAM/Lu probe, and (ii) a 
substrate coated with BCAM (50 µg/ml) and a laminin probe. (b) Box-and-whisker plots of the 
unbinding forces measured at each tested laminin solution concentration shows that the median 
values are nearly consistent (0μg/ml: 66.1pN; 1 µg/ml: 182.2pN; 5 µg/ml: 225.0pN; 10 µg/ml: 
185.3pN; 25 µg/ml: 144.8pN; 50 µg/ml: 138.9pN; Mann-Whitney test for 25μg/ml vs. 50 μg/ml). 
(c) Plots of the substrate density measured at each tested laminin concentration shows that the 
density appears to reach a plateau at 25 µg/ml (median values at 0 µg/ml: 1.63%; 1 µg/ml: 
10.4%; 5 µg/ml: 4.3%; 10 µg/ml: 10.0%; 25 µg/ml: 7.8%; 50 µg/ml: 10.9%; Kruskal-Wallis one-
way test for 10 μg/ml, 25 μg/ml, and 50 μg/ml). The median values and the respective ranges 
are shown. (d) Frequency distributions obtained from SCFS experiments of detachment forces 
between a RBC probe and laminin substrate (50 µg/ml) measured in the (i) absence and (ii) 
presence of bath laminin. The significant reduction in the number of curves showing 
detachment forces, from 66% to 12% (p<0.0001) demonstrates the specificity of the 
measurements. (e) Box-and-whisker plots of detachment forces for human RBC probes (N=2, 
n=10) at each laminin solution concentration. The median values of the detachment forces were 
found to increase with higher laminin concentrations (0 µg/ml: 130.3pN; 1 µg/ml: 113.9pN; 5 
µg/ml: 215.8pN; 10 µg/ml: 243.1pN; 25 µg/ml: 154.9pN; 50 µg/ml: 559.9pN; 100 µg/ml: 
678.0pN), appearing to plateau at the 50 µg/ml concentration. (f) Plot of RBC binding frequency 
shows an increase in binding as laminin substrate concentration increases (median values at 0 
µg/ml: 16.5%; 1 µg/ml: 34.2%; 5 µg/ml: 43.0%; 10 µg/ml: 96.0%; 25 µg/ml:  46.6%; 50 µg/ml: 
39.4%; 100 µg/ml: 72.4%). The median values and the respective ranges are shown. 
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For laminin-functionalized substrates, the percentage of sampled sites where a 
detachment force was detected, reflecting the density of laminin on the substrate, 
increased with higher laminin concentrations (Figure 3-2c; hyperbolic fit). Variability 
reflects different substrate and probe preparations. To determine background noise, 
measurements were recorded on a substrate where the laminin-functionalization step 
was omitted. Interactions were detected in 4.1±0.65% of sampled sites. 
We next determined the effect of different laminin solution concentrations on the 
adherence of RBC probes to laminin substrates. Background noise was quantified by 
using a RBC to probe a substrate where the laminin-functionalization step was omitted. 
Small forces with a median of ~130pN were detected in 16.5% of curves. The interaction 
specificity was demonstrated by performing experiments in 100μg/mL bath laminin, thus 
blocking BCAM/Lu receptors. By recording approach/retraction cycles between RBC 
probes and a substrate functionalized with 50µg/ml laminin, the number of curves 
showing detachment forces reduced from 66% to 12% (p<0.0001, Figure 3-2d) while the 
median detachment force was ~112pN, similar to background noise. Further, detachment 
forces recorded in bath laminin decreased five-fold, from a median value of 559pN to 
106pN (p<0.0001) reflecting bath laminin bound to many BCAM/Lu receptors which 
significantly reduced the propensity for binding of the RBC probe to the laminin substrate. 
RBC probes were used to record forces against each laminin substrate. Detachment 
forces were found to increase with higher laminin solution concentrations (p<0.0001), 
appearing to stabilize around the 50µg/ml concentration (Figure 3-2e). For this 
concentration, we obtained force curves characterized by median detachment forces up  
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to 0.56nN. In contrast, lower concentrations resulted in median detachment forces of less 
than 0.24nN, reflecting the need for a denser substrate laminin concentration to maximize 
BCAM/Lu receptor binding. These detachment force values are comparable to those 
observed for RBCs in other experiments [40]. Moreover, the frequency of RBC binding to 
the laminin substrate also directly increased with laminin concentrations (Figure 3-2f; 
p<0.0001).  
 
From the experiments employed to determine the appropriate solution concentration of 
laminin for substrate functionalization, we found that detachment forces appear to plateau 
at the 50µg/ml laminin concentration (Figure 3-2e), whereas the surface density detected 
via SMFS appears to plateau at ~10µg/ml (Figure 3-2c). Tethered polymer layers are 
comprised of polymer molecules attached to a surface, with a density high enough to 
cause the chains to stretch away from the surface [47, 48]. By maximizing the brush 
height, the free-energy cost is minimized, thus minimizing inter-chain repulsion. This may 
affect the binding of tested cells to proteins attached to a surface. The surface distribution 
 
Figure 3-3 Human RBC adhesion to laminin 
substrates (50 µg/ml) at increasing contact 
times (N=2, n=10). Box-and-whisker plots show 
that the detachment force for RBCs from 
laminin substrates increase from 0.1s to 1s 
contact time and then remains approximately 
consistent. However, the range of measured 
detachment forces increases.  Median forces: 
0.1s: 632.0nN; 1s: 952.9nN; 2.5s: 921.7nN; 5s: 
1046.6nN; 10s: 999.8nN. 
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of a tethered polymer layer can be characterized by the distance between attachment 
points, 𝐷. As 𝐷 approaches the radius of gyration, 𝑅𝑔, of the polymer chain, the molecules 
interact and the polymer layer structure passes from the single-chain (mushroom) regime 
to the brush regime. In the 'mushroom' regime the reduced tethered density, Σ = 𝜎𝜋𝑅𝑔
2, 
where 𝜎 = 1/𝐷2 , is Σ<1, the 'mushroom-to-brush' transition regime occurs for 1<Σ<5, 
and the transition to 'brush' regime occurs at Σ=5. The value Σ=1 corresponds to 𝐷 =
𝐷2 = √𝜋𝑅𝑔 [49]. For the case of laminin, where 𝑅𝑔 ≅ 80 𝑛𝑚 [50, 51], the 'mushroom' 
regime appears for 𝐷1 > 140 𝑛𝑚 and the transition to 'brush' regime occurs at 𝐷 = 𝐷2 =
𝐷1 √5 ≅ 63 𝑛𝑚⁄ . Because the lateral step size was ~31.2nm in SMFS experiments, after 
the first transition point is reached, it is difficult to distinguish between different surface 
densities. Based on Figure 3-2c, we conjecture that the first transition point, from 
‘mushroom’ to ‘mushroom-to-brush’, was reached at the 10µg/ml laminin concentration. 
This is reinforced by the fact that the binding frequency for SCFS experiments plateau at 
the same laminin concentration, meaning that at this concentration, most of the substrate 
is covered with laminin chains in the 'mushroom' form. We found however, that the 
detachment force reached a plateau at ~50μg/ml solution concentration, meaning that the 
binding between all active RBC adhesion receptors and laminin molecules reaches 
equilibrium. We conjecture that this is the second transition point, from 'mushroom-to-
brush' to 'brush' regime, and determined the corresponding concentration of 50μg/ml to 
be most suitable for SCFS assays of human RBCs.  
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3.3.2 Dependence of BCAM/Lu-mediated RBC adhesion on contact time 
To investigate the time dependence of cell adhesion, we varied the contact time of RBCs 
with 50µg/ml laminin substrates between 0.1s and 10s and determined the detachment 
forces. For the 0.1s contact time, the median force required for RBC detachment from 
laminin substrates was ~0.63nN. As the contact time increased to 1s, the median 
detachment force increased to ~0.95nN. For contact times greater than 1s and up to 10s, 
the median detachment force did not significantly change (Kruskal-Wallis test). We opted 
to use the 0.1s contact time for experimental convenience because at higher time scales 
the RBC had a greater probability of detachment from the probe prior to the completion 
of 100 cycles resulting in experimental failure. 
3.3.3 Increases in SCFS detachment forces correlates with increases in total 
forces recorded by SMFS on 1 µm2 membrane regions 
To determine the relationship between single-molecule and single-cell measurements, 
we performed both assays using n=5 cells from human subjects (N=3). SMFS 
experiments probed 1µmx1µm areas of the RBC surface with a lateral resolution of 
~31.2nm, enabling us to measure single-rupture events. For the SCFS assay, RBCs 
probed a laminin-functionalized substrate (50µg/ml laminin solution concentration) with a 
contact time of 0.1s. For comparison of SMFS to SCFS, the resultant total force 
associated with each 1µmx1µm membrane area was calculated as the product of the 
frequency of detected events and the mean detachment force. For example, an area with 
a mean detachment force of 39.51pN detected in 2.83% of sampled sites yields a total 
force of 1.15nN. Resultant total forces ranged from 0.77nN to 3.92nN. In contrast, 
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detachment forces obtained between single RBCs with a laminin substrate were lower, 
ranging from 0.11nN to 1.8nN (Figure 3-4a). The mean detachment force for an entire 
RBC corresponds to the simultaneous formation of ~20 active bonds between BCAM/Lu 
proteins on the RBC surface and laminin on the substrate, calculated by dividing the 
average single-cell detachment force by the average single-molecule detachment force. 
The median detachment force of one BCAM/Lu receptor from laminin was found to be 
40.62pN. We note that the SCFS technique reflects the overall RBC adhesion to the 
substrate, whereas SMFS measurements represent direct ligand-receptor interactions.  
Since multiple cells were tested from each subject, detachment forces could be compared 
between subjects. The Pearson correlation test was used to determine the strength of 
relationship between SMFS and SCFS assays (Figure 3-4b). We found that SMFS 
resultant mean total force correlated strongly with the mean detachment force obtained 
via SCFS (r=0.99, R2=0.99). Due to the fact that SCFS measurements reflect currently 
active bonds, as well as innate cellular features, they can be used as an innovative tool 
to study RBC adhesion. However, it is important to note that detachment of the cell from 
the substrate is a complicated process, and the detachment force obtained is a result not 
only of receptor-ligand binding strength and spatial distribution of receptors on the cell 
membrane but also of other factors such as membrane fluctuations, cellular elasticity, and 
cell shape [28, 52, 53]. RBC deformability plays a significant role in SCFS measurements, 
whereas SMFS measurements represent direct ligand-receptor interactions. Increases in 
RBC compliance may allow the cell to spread, leading to an increased number of ligand-
receptor interactions and in effect, greater detachment forces measured via SCFS [42].  
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Figure 3-4. Correlation of single-cell measurements with traditional SMFS 
measurements. (a) Box-and-whisker plot of the detachment forces from SMFS and 
SCFS assays. Experiments were performed on 5 cells from each human sample (N=3). 
SCFS experiments used single RBCs to probe a laminin functionalized substrate 
(50µg/ml) with a contact time of 0.1s. SMFS experiments probed BCAM/Lu receptors 
on 1 µm x 1 µm areas of the RBC surface with a laminin-functionalized probe. The 
resultant total force for each area was calculated as the product of the frequency of 
detected events and the mean detachment force. (b) Correlation of the mean resultant 
total force on 1 µm x 1 µm areas of the RBC surface obtained via SMFS with the mean 
detachment force obtained via SCFS measurements (Pearson correlation test; r=0.99, 
R2=0.99). Each plotted point represents 5 tested cells from one healthy subject. 
 
3.3.4 cAMP-dependent modulation of red blood cell adhesion to laminin via 
BCAM/Lu 
To establish the sensitivity of the assay in the adhesion of BCAM/Lu to laminin, we 
investigated changes in the detachment force of single RBCs with laminin via 
pharmacologic modulation of the cAMP-signaling pathway. Previous experimental 
approaches utilizing flow adhesion assays have shown that the interaction between 
BCAM/Lu and laminin is mediated by cAMP-dependent PKA [54]. Stimulation of the β2-
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adrenergic receptor (β2-AR) [55, 56] activates the G-protein coupled receptor Gαs, which 
stimulates adenylyl cyclase (AC) [57]. AC catalyzes the conversion of adenosine 
triphosphate (ATP) to cAMP, resulting in PKA activation and ensuing BCAM/Lu-laminin 
adhesion. In human RBCs, basal cAMP levels are controlled through the activity of 
phosphodiesterases [58, 59], which limit the signaling lifespan of cAMP and the distance 
it can diffuse from its production site [60]. 
RBCs were treated with forskolin (30μM, FSK), a strong AC activator. Compared to 
untreated RBCs, forskolin-treated RBCs exhibited significantly higher detachment forces 
(Figure 3-5a,b,e; p<0.0001, Mann-Whitney U test). To quantify the effect of direct PKA 
inhibition on the RBC detachment force from laminin, RBCs were treated with KT-5720 
(1μM), a PKA inhibitor, which resulted in a significant decrease in detachment forces from 
baseline (Figure 3-5c; p<0.0001). Based on these results, we conjecture that RBCs 
maintain varying intracellular levels of tonic PKA [60, 61]. We speculate that this tonic 
PKA is modulated by cAMP levels and must be raised for the activation of BCAM/Lu 
receptors to occur, resulting in elevated adhesion to subendothelial laminin. The reduction  
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Figure 3-5. Single-cell force spectroscopy can clearly detect significant changes in 
RBC adhesion to laminin substrates (50µg/ml) following treatment with biochemical 
agents modulating the cAMP-dependent pathway. (a) Frequency distribution of the 
detachment forces associated with healthy RBCs at baseline (N=3, n=15) shows a 
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in the number of active BCAM/Lu receptors on the RBC surface following inhibition of 
PKA activity with KT-5720, reflected by the significant decrease in detachment forces, is  
suggestive of a tonic drive. Even in the absence of PKA inhibitors and activators, PKA 
exerts a sustained, steady-state activation of BCAM/Lu receptors. Finally, the physiologic 
implication of cAMP-stimulated adhesion was studied by treating RBCs with epinephrine 
(1μM), a hormone which stimulates the β2-AR. This resulted in a significant increase in 
the detachment forces compared to baseline (Figure 3-5d; p<0.0001). These data 
demonstrate that the single-cell AFM assay can detect differences in the detachment of 
whole RBCs from a laminin substrate in response to pharmacologic modulation (Figure 
3-5e).  
 
3.4 Conclusion 
SCFS was established as a method to quantify the strength and modulation of adhesion 
of human RBCs to functionalized substrates. Using SMFS and SCFS, we determined the 
median force of 594.2pN . (b) Measurement in FSK (30 µM) indicates a significant shift 
of the recorded detachment forces (p<0.0001, Mann-Whitney U test) and an increase 
in the median detachment force to 837.9pN . (c) Measurement in KT-5720 (1 µM) 
indicates a significant shift of the detachment forces (p<0.0001) and a decrease in the 
median detachment force to 148.3pN. (d) The physiologic implication of cAMP-
stimulated adhesion was studied. Measurement in epinephrine (1 µM) indicates a 
significant shift of the detachment forces (p<0.0001) and an increase in the median 
detachment force to 825.8pN. (e) Box-and-whisker plots of detachment forces obtained 
for healthy RBCs from laminin substrates in the presence and absence of biochemical 
agents known to modulate cAMP-dependent adhesion; (*) indicates p<0.0001 and (**) 
indicates p<0.016. 
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appropriate solution concentration of laminin to utilize for substrate functionalization via 
the density of protein adsorption to the substrate. From these tests, we determined the 
50µg/ml solution concentration of laminin to be most effective. Then, we probed laminin 
substrates with RBCs using contact times ranging from 0.1s to 10s. We chose 0.1s 
because of the low potential for experimental failure prior to the completion of 100 
approach/retract cycles and for comparison between single-molecule and single-cell 
measurements. We found a significant correlation between results from SMFS 
measurements probing BCAM/Lu with a laminin-functionalized probe and SCFS 
measurements probing a laminin substrate with an RBC probe. Finally, we established 
that SCFS can detect variations in the detachment force of RBCs to laminin based 
primarily on the number of active BCAM/Lu receptors, which was modulated via 
biochemicals affecting the cAMP-PKA pathway. This study shows important implications 
for AFM-based SCFS measurements in understanding and evaluating the pharmacologic 
response of adhesion receptors on RBCs. 
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Chapter 4: Red Blood Cell Specific Adhesion and Mechanical 
Properties in Microfluidics 
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4.1 Introduction 
Sickle cell disease (SCD) is a genetically inherited disorder characterized by painful vaso-
occlusive crises in which blood flow to parts of the body is obstructed [1]. Vaso-occlusion 
is the result of interactions between blood cells and the endothelium [2-4]. It has been 
shown that the adhesive behavior and viscoelastic response of SS-RBCs are important 
factors in vaso-occlusion [8]. SS-RBC adhesion to specific proteins, such as human 
integrin 𝛼𝑣𝛽3, expressed on the endothelium has been implicated as part of the 
mechanism that triggers vaso-occlusive crises [9, 10]. During a vaso-occlusive crisis 
adherent SS-RBCs in the vasculature obstruct other SS-RBCs due to their viscoelastic 
and mechanical properties [13, 14]. 
A number of experimental tools have been used to quantify SS-RBC adhesion to proteins 
expressed on the endothelium. To this end, atomic force microscopy (AFM) has been 
employed in single-molecule force spectroscopy (SMFM) and single-cell force 
spectroscopy (SCFS) assays [10, 15, 16]. These assays offer insight into molecular level 
interactions, but only a few RBCs can be tested this way under each condition. In contrast, 
perfusion chambers and microfluidic devices have been utilized with the same aims [11, 
70]. These setups provide the potential for concurrent high-throughput assays that are 
more clinically relevant than AFM-based techniques. However, current microfluidic 
assays face many design challenges in terms of functionalization and flow control. 
Specifically, physical adsorption of targeted proteins directly on the microchannel 
surfaces has become a staple of microfluidic assays due to the ease of application and 
because of the difficultly in utilizing other strategies when microchannels are assembled 
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using oxidative sealing [71]. Unfortunately, this functionalization technique produces 
weak and unstable immobilization bonds between the proteins and the substrate. In 
addition, proteins do not bind specifically, orient themselves randomly, and are capable 
of forming as many bonds as they have binding sites [72]. This can lead to experimental 
protocols that are marred by background RBC adhesion to the substrate itself and 
adhesion to protein binding sites that are not of interest to the specific study. On the other 
hand, the use of volumetric flow pumps in microfluidic assays prevents instant changes 
in flow parameters, thus severely limiting options in assay design. 
The mechanical properties of wildtype RBCs have been explored both empirically and in 
simulations [73-75]. As such, optical tweezers and micro-pipettes have also been 
employed to study SS-RBC viscoelastic properties [8, 76]. Also, the mechanical 
properties of SS-RBCs have been investigated using AFM [77]. Because these assays 
feature direct manipulation of individual SS-RBCs they are time consuming, have low 
throughput, and contain generalizations and potential errors arising from the type and 
shape of the device. Tangentially, a microfluidic assay enabled by a custom made 
pressure driven flow has been used to study viscoelastic properties of sickle cell trait 
RBCs [78]. 
In this work, we propose a microfluidic approach that addresses the complications found 
in adhesion assays by using a functionalization strategy in which a known protein binding 
site covalently bonds with the substrate in order to create a uniformly dense functionalized 
surface. In order to facilitate the functionalization, the microchannel is assembled through 
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aspiration, which keeps the functionalized areas inside of the microchannel untouched 
[79].  
In concert with this design, a pressure controlled pump allows us to introduce a well-
controlled flow inside the microchannel. The use of a pressure pump allows us to quantify 
SS-RBC adhesion to a functionalized substrate not only by the fraction of remaining 
adherent RBCs at the end of each experiment but also by their ability to withstand wall 
shear stress increases during experiments. This feature empowers us to quantify the 
mechanical properties of SS-RBCs by instantly modulating the flow while tracking the 
morphological changes in SS-RBCs that have adhered directly to a glass substrate. 
4.2 Materials and Methods 
4.2.1 Equipment 
Precise and steady control of microfluidic flow was achieved with a pressure controller 
(OB1 Microfluidic Flow Control System; Elveflow, Paris, France). Both the inlet and outlet 
ports of the microfluidic device were independently controlled by the pressure controller 
in order to increase precision. The microchannel was observed and recorded digitally by 
an Orca-Flash 2.8 high speed camera (Hamamatsu Photonics K.K.; Hamamatsu City, 
Japan) attached to an Olympus IX73 inverted microscope (Olympus Corporation; 
Shinjuku, Tokyo, Japan). A diagram of the setup is shown in Figure 4-1A. In adhesion 
experiments a 20x magnification objective lens, numerical aperture (NA) of 0.45, was  
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used, while recovery experiments utilized a 40x magnification objective lens, NA of 0.6. 
The high speed camera captured 45 frames a second. A custom LabVIEW user interface 
 
Figure 4-1 A. Graphic showcase of the experimental equipment. B. A computer-aided 
design rendering of the polydimethylsiloxane component of the microfluidic assembly 
exhibiting the aspiration network around the microchannel. C. A processed background 
image of a video recorded during an RBC to endothelial protein adhesion assay where 
individual adherent RBCs are identified. The paths of non-adherent RBCs can be made 
out as blurs. 
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was used to control both devices digitally and record pressure readings and video footage 
simultaneously. 
4.2.2 Microchannel fabrication 
Polydimethylsiloxane (PDMS) microchannels were created using photolithography to give 
all features a height of approximately 32 m . The master mold was created following 
standardized permanent epoxy negative photoresist processing guidelines provided by 
MicroChem (USA; Westborough, MA). To summarize briefly, the master mold was 
created by covering a 100 mm diameter silicon wafer with SU-8 2025 negative 
photoresist, spin coated to achieve the desired feature height, covered with the mask of 
the design, and exposed to ultraviolet (UV) light in order to crosslink the polymer. The 
relief structure was then developed using 1-Methoxy-2-propyl acetate (SU-8 developer) 
and covered with PDMS prepolymer, which was then cured to create the PDMS 
elastomer. The PDMS microchannels were cut from the wafer and peeled off from the 
master mold. The microchannel device featured a 15 mm long and 1 mm wide 
microchannel, connected at either end to 6 mm diameter antechamber wells. The size of 
the wells was necessary to promote structural stability of the microchannel. 
The microfluidic device was attached, through aspiration, to a functionalized glass slide 
substrate (See Figure 4-1B) [79]. This method of assembly allows substrates to be 
functionalized before the device is assembled since the functionalization is not altered or 
destroyed during assembly, as in oxidative sealing. Truncated and polished 20 gauge 
needles were employed as the inlet and outlet ports of the microchannel, and were 
connected to 6 mm diameter antechamber wells of the microfluidic device. The aspiration 
 46 
 
network was connected by a 2mm diameter tygon tube to a vacuum pump that supplied 
a negative pressure of 75 kPA. The microchannel was brought into contact with the 
functionalized glass slide substrate while submerged in phosphate buffered saline (PBS), 
in order to prevent the formation of an air bubble inside the microchannel. 
4.2.3 Functionalization 
Human integrin 𝛼𝑣𝛽3 (EMD Millipore; Billerica, MA, USA) was covalently bound to an N-
hydroxysuccinimide (NHS) functionalized glass slide (NHS surfaces; MicroSurfaces, Inc., 
Englewood, NJ, USA) in order to facilitate a uniform coating [72]. In order to bind the 
protein, it was deposited onto the slide at a concentration of 270 
𝑚𝑔
𝑚𝐿
 in Triton-X 100 and 
incubated on the slide for 20 minutes at 37°C. The excess solution was then rinsed off 
the slide with PBS, the slide was coated with a proprietary buffer solution (MicroSurfaces, 
Inc., Englewood, NJ, USA) to remove unbound NHS groups and incubated for 30 minutes 
at room temperature to this end. The excess buffer solution was rinsed off the slide with 
PBS. The functionalized slide was then stored in PBS and immediately used. 
4.2.4 Sample Preparation 
This study was approved by the Institutional Review Boards of the UCONN Health Center 
and UCONN-Storrs. Volunteers with SCD, at least 18 years of age, were eligible to 
participate in this study. RBCs from consented volunteers were separated from freshly 
drawn, heparin-anticoagulated, venous blood by centrifuge, at a relative centrifugal force 
of 500g for 10 minutes at 4° C. Afterward, the buffy white coat and plasma were removed 
by aspiration, and the RBCs were washed three times with Alsever’s solution, a saline 
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solution used to store blood [80]. RBCs were diluted down to a hematocrit of 0.5% for the 
adhesion assay and 1% for the viscoelasticity assay in Alsever’s solution before being 
introduced into the microchannel. This hematocrit was selected in order to maximize the 
acquisition of useful images during video recording, such that there were as many non-
overlapping RBCs in each frame as possible. 
Epinephrine was added to the SS-RBC solution to produce a final concentration of 
16.4 𝑛𝑀. The SS-RBCs solution with Epinephrine was incubated for 30 minutes before 
the experiment was conducted. Propranolol was added to the SS-RBC to produce a final 
concentration of 10 𝜇𝑀. The SS-RBC solution with propranolol was incubated for 30 
minutes before the experiment was conducted. 
4.2.5 Adhesion Assay 
SS-RBCs from one concenting patient in Alsever’s Solution (Sigma-Aldrich, St. Louis, 
MO, USA) at a 0.5% hematocrit were introduced into the microchannel and allowed to 
adhere to the functionalized substrate for 10 minutes at a pressure drop that produced a 
0.1 
𝑑𝑦𝑛𝑒𝑠
𝑐𝑚2
 wall shear stress. After this initial period, all RBCs in a 3 𝑚𝑚2 area inside the 
microchannel were recorded. The pressure drop across the microchannel was then 
increased to produce 1, 5, 10, 20, and 30 
𝑑𝑦𝑛𝑒𝑠
𝑐𝑚2
 wall shear stress and the adherent RBCs 
were recorded in the same 3 𝑚𝑚2 area 1 minute after each increase. After all wall shear 
stresses measurements were taken, the microchannel was discarded. 
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4.2.6 Viscoelasticity Assay 
Untreated, baseline, SS-RBCs from one concenting patient, in Alsever’s Solution at a 1% 
hematocrit were introduced into the microchannel and allowed to adhere to the glass 
substrate for 10 minutes with no pressure drop across the microchannel. The recoveries 
of adherent SS-RBCs due to the instant change in wall shear stress from 1 
𝑑𝑦𝑛𝑒𝑠
𝑐𝑚2
 
(physiological wall shear stress) to 0 
𝑑𝑦𝑛𝑒𝑠
𝑐𝑚2
 were recorded. 
4.2.7 Data Processing 
A custom MATLAB script was used to detect and quantify adherent RBCs. A background 
image of each recorded video was created by averaging all individual pixel values over 
all frames. This filtering method obfuscates all moving objects and retains all stationary 
ones in the background image. The background was then cropped to the area of interest, 
devignetted, and sharpened using unsharp masking. The edges of all RBCs were 
quantified by the Canny edge detection algorithm. The convex hulls of all object edges 
were then labelled, and sorted based on size: objects smaller than a potential RBC 
(smaller than 4 𝜇𝑚 in diameter) were discarded while objects larger than a potential RBC 
(larger than 12 𝜇𝑚 in diameter) were broken up into multiple objects using the watershed 
algorithm. The final set of objects were again sorted by size such that objects too small 
(smaller than 4 𝜇𝑚 in diameter) or too large  to be an RBC (larger than 12 𝜇𝑚 in diameter) 
were discarded. The remaining objects were counted and overlaid on the original image, 
so that the computed result could be double checked and adjusted manually to ensure its 
accuracy (see Supplmentary Figure 4-S1).  
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In viscoelastic experiments, RBCs were identified on a frame by frame basis after the 
frames were cropped, sharpened, and devignetting. Each individual RBC was identified 
and tracked throughout a video. The tracking was automated using a custom MATLAB 
code, and the results were verified manually and corrected where necessary. RBC 
morphology was determined by fitting the identified shape of the RBC with an ellipse. 
Only adherent yet freely deformable and mobile RBCs were selected, manually, for 
processing (see Supplmentary Figure 4-S2 for an example of SS-RBC morphology at 
different applied wall shear stresses).  
Though these simple MATLAB codes have been highly customized for our use and are 
of little scientific interest in and of themselves, we have made them available online 
(http://www.engr.uconn.edu/%7Egelyko/additionalsoftware.html) as an example of the 
exact processing logic, algorithms, and working parameters we used. 
4.3 Results and Discussion 
4.3.1 Adhesion Assay 
One patient’s SS-RBC’s affinity to adhere to a 𝛼𝑣𝛽3 functionalized substrate was 
modulated by epinephrine, an agonist, which has been shown to increase SS-RBC 
adhesion to the endothelial protein [9]. Epinephrine produces this effect by upregulating 
cAMP in RBCs and stimulating protein kinase A, which increases SS-RBC adhesion [2]. 
Consistent with previous findings, the adherent population of SS-RBCs treated with 
epinephrine was not only greater but resisted higher wall shear stresses than SS-RBCs 
not treated with epinephrine (See Figure 4-2). Additionally, we predict that antagonists, 
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such as propranolol, may not only block the action of agonists, but actively reduce SS-
RBC adhesion to a 𝛼𝑣𝛽3 functionalized substrate. Consistent with this conjecture, we 
found that the adherent population of SS-RBCs treated with propranolol was lower and 
could not withstand wall shear stresses as high as that of untreated SS-RBCs (see Figure 
4-2).  
 
Figure 4-2. Adherent populations of 
untreated SS-RBCs alongside those 
treated with epinephrine and propranolol 
relative to their respective initial adherent 
populations to a substrate coated with 
human integrin 𝛼𝑣𝛽3 at increasing wall 
shear stresses. When treated with 
epinephrine, SS-RBCs adhere in greater 
relative numbers at larger stress than 
when untreated. SS-RBCs treated with 
propranolol appear to adhere in fewer 
relative numbers than untreated SS-
RBCs. Due to the large number of initial 
SS-RBCs (n>300 for each data point), the 
95% confidence intervals of each data 
point, if displayed, would be obscured 
entirely by the symbols representing the 
measured values. 
  
Each measurement is based on a minimum of 300 initially adherent RBCs spread 
uniformly over a 3 𝑚𝑚2 area. Background adhesion, evaluated with a slide coated only 
with the background PEG layer, was found to be negligible below a shear stress of 5 
𝑑𝑦𝑛𝑒𝑠
𝑐𝑚2
 
and non-existent above (data not shown). Thus, we are quantifying, almost exclusively, 
SS-RBC adhesion to human integrin 𝛼𝑣𝛽3. By incrementally increasing wall shear stress 
on the group of adherent SS-RBCs and recording each change, we are able to 
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meaningfully measure the strength of adhesion of SS-RBCs to the specific receptor 𝛼𝑣𝛽3 
with high throughput. Due to this uniformity and the large number of processed cells, we 
expect that the reported values are true for the entire sample and that this precision will 
remain consistent in future patient samples. As with AFM measurements, we expect to 
observe large variability between samples drawn from different patients and even 
samples drawn from the same patient on different dates. However, when we treated the 
patient sample with epinephrine and propranolol the modulation of the adhesion was in 
agreement with the expected trend that we have previously reported based on AFM. We 
expect that using the proposed method we will be able to measure the same modulation 
in future patient samples. 
We note that the adhesion levels of individual RBCs from the same sample are diferent 
from cell to cell. This has been observed in whole RBC adhesion experiments where the 
adhesion force between a RBC and a functionalized substrate was measured via AFM 
[16] and in single molecule force spectroscopy experiments where the expression of 
active adhesion receptors was measured [15, 81]. Because of this, we expect that the 
same level of wall shear stress will not have the same effect on all RBCs in terms of 
detachment from the substrate. Nonetheless, we observed that higher wall shear stress 
results in a lower adherent fraction and after a sufficiently high value almost, depending 
on the RBC adhesion level, all RBCs are detached.  
4.3.2 Continuous Flow and RBC Elongation 
Based on the pressure pump’s internal pressure sensors, which record pressure drop 
experienced across the microchannel every 0.1 seconds, we have found that the  
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response time of our microfluidic system is 0.1 seconds at the slowest. Observations of 
RBC morphology suggest that the system responds even faster and clearly indicate that 
continuous input pressure changes are experienced across the microchannel 
corresponding to continuous pressure changes. We have verified this by applying an 
oscillating pressure drop across the channel and simultaneously measuring the major and 
 
Figure 4-3A. The extension ratio of an adherent red blood cell (RBC) follows the 
oscillating wall shear stress applied on it closely, demonstrating that the measured 
pressure drop across the microchannel as well as the RBC morphology are accurately 
tracked. B. The major and minor axes of an RBC as it undergoes recovery from a wall 
shear stress of 7 
𝑑𝑦𝑛𝑒
𝑐𝑚2
 near the 2 second mark. The RBC recovery is curve-fit to the 
solution of the Kelvin-Voigt model in which no external forces are present. C-D. Box 
plots of the measured shear modulus and viscosity of adherent SS-RBCs (𝑛 = 21) as 
they recovered from 1 
𝑑𝑦𝑛𝑒
𝑐𝑚2
 wall shear stress. The notches on the box-plots represent 
the 95% confidence intervals of the measured medians. 
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minor axes lengths of an adherent RBC and evaluating its elongation index as 𝐸𝐼 =
𝑚𝑎𝑗𝑜𝑟 𝑎𝑥𝑖𝑠 − 𝑚𝑖𝑛𝑜𝑟 𝑎𝑥𝑖𝑠
𝑚𝑎𝑗𝑜𝑟 𝑎𝑥𝑖𝑠 + 𝑚𝑖𝑛𝑜𝑟 𝑎𝑥𝑖𝑠
 (see Figure 4-3A).  
4.3.3 SS-RBC Recovery 
The viscoelastic properties of the SS-RBC membrane were quantified by measuring the 
shear modulus and viscosity using the Kelvin-Voigt model for a Neo-Hookean near 
incompressible material with linear viscous response:  
𝑇𝑠
2𝜇
=
1
4
(𝜆2 − 𝜆−2) + 𝑡𝑐
𝜕 ln(𝜆)
𝜕𝑡
 , 
where 𝜇 is the membrane shear modulus, 𝑡𝑐 ≡
𝜂
𝜇
 is the characteristic time, 𝜂 is the 
membrane viscosity, 𝜆 =
𝑑𝑒𝑓𝑜𝑟𝑚𝑒𝑑 𝑚𝑎𝑗𝑜𝑟 𝑎𝑥𝑖𝑠 𝑅𝐵𝐶 𝑙𝑒𝑛𝑔𝑡ℎ
𝑢𝑛𝑑𝑒𝑓𝑜𝑟𝑚𝑒𝑑 𝑚𝑎𝑗𝑜𝑟 𝑎𝑥𝑖𝑠 𝑅𝐵𝐶 𝑙𝑒𝑛𝑔𝑡ℎ
 is the extension ratio, and 𝑇𝑠 =
𝑇1−𝑇2
2
 is the membrane shear stress where 𝑇1 =
𝜏 ∗ 𝑑𝑒𝑓𝑜𝑟𝑚 𝑅𝐵𝐶 𝑎𝑟𝑒𝑎
𝑑𝑒𝑓𝑜𝑟𝑚𝑒𝑑 𝑅𝐵𝐶 𝑚𝑖𝑛𝑜𝑟 𝑙𝑒𝑛𝑔𝑡ℎ
 and 𝑇2 = 0 are the 
in-plane principal membrane stresses, and 𝜏 is the wall shear stress applied on the RBC 
[75, 82]. The shear modulus was obtained via the expression 𝜇 =
2𝑇
(𝜆2−𝜆−2)
,  where 𝜆 is the 
extension ratio between two steady-state conditions. The viscosity was evaluated as 𝜂 =
𝜇 ∗ 𝑡𝑐 where 𝑡𝑐 was found by curve fitting the relaxation data of the instantaneous 
extension ratio 𝜆(𝑡) with the analytical solution 𝜆(𝑡) =  √
Λ + exp (−𝑡/𝑡𝑐)
Λ − exp (−𝑡/𝑡𝑐)
 of the governing 
equation for zero applied membrane forces (see Figure 4-3B), where 𝑡 is the time, Λ =
𝜆𝑚
2 +1
𝜆𝑚
2 −1
, and 𝜆𝑚 is the extension ratio at the instance when the applied membrane forces are 
set to zero.  
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The viscosities and shear moduli of SS-RBCs were measured using this method as 
shown in Figure 4-3C and 4-3D. The measured shear moduli are of the same order of 
magnitude, though nominally higher, as those reported by [82]. This is consistent with our 
expectations, since the aforementioned work investigated wild type RBCs and previous 
efforts from our lab have measured higher Young’s Moduli in SS-RBCs with respect to 
their wild type RBC counterparts [83]. The time constant, 𝑡𝑐, was found to be on the same 
order of magnitude as the original findings by [75], signifying that the reported viscosity 
measurements are in agreement with both works. The width of the 95% confidence of the 
shear modulus measurements (~2
𝜇𝑁
𝑚
) is a product of the large number of processed 
RBCs, and we expect future processed samples to continue to produce measurements 
of comparable precision. 
4.3.4 Conclusion 
The implemented experimental setup presents an opportunity to quickly and precisely 
quantify the mechanical and pharmacological properties of SS-RBCs in many different 
assays. This is enabled by the combination of equipment, specifically the high-speed 
camera and the precise and instantly modifiable pressure flow, the surface 
functionalization protocol, and custom image processing software. Minor tweaks to the 
assay parameters, such as the concentration of endothelial protein during 
functionalization, may also be appropriate to maximize the sensitivity of the system and 
elucidate SS-RBC properties. The current setup can be easily modified to enable 
experiments under controlled oxygen levels.  
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These experimental methods may potentially also be conducted in similar assays on 
wildtype RBCs or in efforts to study other related diseases, such as malaria or diabetes, 
where either RBC adhesion or mechanical behavior plays a major role in pathology. The 
same advantages and improvements presented in this report may prove to be applicable 
is such studies. Thus, this potential is an avenue for future work in this area.  
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4.4 Supplementary Information 
 
Supplementary Figure 4-S1. The intermediate outputs of the custom video data 
processing MATLAB script used to detect and quantify adherent RBCs. A. A typical 
frame of a recorded video. B. The background of the video. Note that only adherent 
RBCs can remain in the image. C. The devignetted, cropped background. D. Output of 
the Canny edge detection algorithm on the processed background. E. The convex hull 
regions of all edges. F. Independent regions are identified, labelled, approximated by 
an ellipse, processed based on size (rejected or split), and finally the approximated 
ellipses are overlaid over the devignetted and cropped video background. The user 
adjusts program count by accounting for missed or lumped cells as well as false-
positive identification of objects other than SS-RBCs. 
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Supplementary Figure 4-S2. The approximated morphology of a SS-RBC, denoted 
cell 2, that has been deformed at A  7
𝑑𝑦𝑛𝑒𝑠
𝑐𝑚2
 wall shear stress, B  5
𝑑𝑦𝑛𝑒𝑠
𝑐𝑚2
 wall shear 
stress, and C  0
𝑑𝑦𝑛𝑒𝑠
𝑐𝑚2
 wall shear stress. 
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Chapter 5: Assembly for Measuring the Viscosity of Fluids Using 
Microchannels 
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5.1 Introduction 
The viscosity of nearly all liquid products, whether consumer, industrial, or medical in 
nature, must be ascertained during both formulation and quality assurance. The viscosity 
of body fluids, such as whole blood and blood plasma has been shown to be a powerful 
tool in cardiovascular health evaluation and in monitoring several diseases. For instance, 
non-medical rheology measurements are important in both the development and the 
quality assurance of inks[113], paints[114], petroleum[115], cosmetic products[116, 117], 
oils[118], coatings[119], adhesives[120], consumer care products[121], extrusion 
polymers[122], foods and beverages[116, 117, 123], and pharmaceutical 
formulations[117, 124]. 
Both viscometers and rheometers suffer from numerous drawbacks. Most notably, such 
devices require a significant amount of sample liquid, typically a full vial. This requirement 
often makes such instruments unfeasible in applications where the sample is expensive, 
such as in bioprinting inks. Rheometers are also typically heavy and require peripheral 
equipment to operate. This immobility prevents technicians from bringing the device to 
the sample. Constant cleaning is necessary between the measurement of every sample. 
The measurement process itself can be very slow. One sample can take half an hour or 
more to process. Such a long processing time may exclude samples which undergo a 
change, such as adhesives, inks, and epoxies. Many affordable models also necessitate 
the need for a trained technician with an engineering background and a familiarity with 
the theoretical expressions exploited by their device. Without double checking the 
measurement data, these instruments may produce results that are 10 or 100 times off 
 62 
 
from reality. The price of trained personnel combined with the long measurement times 
can costs companies significant sums. Instruments which fix most of these issues are 
orders of magnitude more expensive than their counterparts. 
Due to the technological challenges involved, body fluid viscosity measurements such as 
whole blood viscosity (WBV) and blood plasma viscosity have not been a prevalent 
medical measurement despite evidence of their value in cardiovascular risk management 
and in evaluating cognitive ability in Alzheimer’s Disease. High WBV measurements have 
been strongly correlated with cardiovascular events, such as stroke and ischemic heart 
disease. A 1996 study measured the WBV of more than 1,500 people and followed up 
with them 5 years later in order to identify any cardiovascular events. The investigators 
found WBV to be a powerful long term predictor of cardiovascular events, stronger even 
than conventional risk factors such as LDL cholesterol, smoking, or diastolic blood 
pressure [125]. A recently published study that followed more than 3,000 subjects over 
the course of approximately 17 years found similar results for both WBV and plasma 
viscosity [126]. A number of other studies have reported comparable findings [127, 128]. 
An affordable point-of-care rheometer may also be of particular useful in Alzheimer’s 
Disease evaluation. WBV has been found to be correlated with cognitive ability and can 
be used as a biomarker in monitoring the disease  [129, 130]. In Waldenström’s 
Macroglobulinemia (WM), which is a type of cancer that causes hyperviscosity syndrome 
(HVS), a condition in which the viscosity of blood is too high, oncologists actively need to 
monitor their patients’ blood plasma viscosity [131]. Other disease which produce the risk 
of HBS include multiple myeloma [132], paraproteinemia [133], and polycythemia [134]. 
Blood viscosity measurements may also be useful in monitoring risk of leg ulceration and 
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possibly vaso-occlusive episodes in sickle cell disease [135]. We further hypothesize that 
a small sample body fluid rheometer may also be of consequence in dialysis, diabetes 
monitoring, as well as in sports medicine. 
5.2 Final Product 
We are have designed a small-sample microfluidics-based rheometer that will provide 
viscosity results over a continuous range of shear rates in at most 5 minutes. Our device 
will not require peripheral equipment to operate and will also be portable. The device itself 
consists of two parts: the core device that conducts and records the measurements and 
a refillable microchannel cartridge that is the only component which comes in contact with 
any liquid sample. This is particularly useful for certain liquids, such as inks, adhesives, 
epoxies, and especially in body fluids because the device will not need regular cleaning 
or sterilization between uses. Furthermore, the cartridges will be tagged with an RFID 
chip that will provide important information to the core device in order to improve the 
fidelity of the measurement and ensure that only our cartridges can be used with the core 
device. Thanks to the nature of microchannels, the rheometer will only require a small 
volume of the sample liquid for a viscosity measurement. We anticipate that 500 𝜇𝐿 of a 
sample will be necessary at most per measurement. For WBV measurements, medical 
practitioners will only need to administer a finger prick to their patients in order to acquire 
enough blood for a complete measurement and a full blood draw procedure will not be 
necessary. In bioprinting inks the use of this device will produce significant savings by 
reducing the waste of expensive sample. The device will also be able to measure plasma 
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viscosity, an already established laboratory measurement, as well as any low viscosity 
body fluids and industrial liquids. 
To perform the measurement, our rheometer will continuously record the position of a 
liquid sample as it traverses a microchannel. This information can be used in combination 
with the microchannel dimensions to determine the sample viscosity at a continuous 
range of shear rates. The shear rate range can be controlled by the microchannel 
dimensions. The sample will traverse the microchannel from end to end by means of 
capillary pressure, which must be quantified during each measurement. If the 
measurement of capillary pressure is 
not reliable enough for our customers 
or does not provide them with sufficient 
measurement options, samples will be 
made to traverse the microchannel by 
means of a controlled negative 
pressure. This addition, however, will 
still require a measurement of capillary 
pressure because to it is non-
negligible.  The measurement of liquid 
viscosity based on the detection of the 
position of the interface and its speed in a microchannel was established by Srivastava 
et al [1]. The biggest challenge for the automation of this method is the detection of the 
sample location. The answer to this challenge has typically been the digital image 
processing of captured video. However, this technique is computationally demanding 
 
Figure 5-1 A mock-up of the final device with an 
inserted cartridge. 
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because the traveling interface of the sample must be established through digital image 
processing of every video frame. This method requires the use of a computer powerful 
enough to quickly process the necessary video processing algorithms. Our device meets 
this challenge in tracking and processing the sample through the microchannel by 
exploiting the increase of the absorption and scattering of light that illuminates the channel 
as the sample flow progresses through it. Essentially, a bright collimated light is emitted 
above the microchannel and is recorded by a photodiode below it. As the sample enters 
and traverses the microchannel less and less light can reach the photodiode due to the 
shadow the sample casts. The signal from the photodiode can processed to find the exact 
positions of the sample column along the microchannel with respect to time and then 
establish the flow speed. A mockup of what the final device may look like can be seen in 
Figure 5-1. A diagram displaying the physical principles used by the sensor is presented 
in Figure 5-2. 
5.3 Technical Discussion 
We can quantify liquid viscosity by recording the position and velocity of a liquid column 
as it is introduced to and traverses a microchannel open on both sides to atmospheric 
pressure. We measure the position of the liquid column through a single photodiode 
receptor, essentially a 1-pixel camera (Figure 5-2). In order to track and record the 
process, we first record how much collimated light passes through an empty 
microchannel. As a liquid enters and begins to traverse the microchannel it obscures the 
light source from the photodiode and we continuously record the drop in the voltage 
across the photodiode. Once the liquid has traveled the entire length of the microchannel 
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the voltage levels out and the cartridge can be removed from the device. The recorded 
voltage signal can then be converted directly to liquid column length. To do so we first 
normalize the signal by the final and initial voltage levels and then we multiply the length 
of the microchannel cartridge by 1 minus the signal. The resultant signal is the position of 
the liquid column over time and its numerical derivate with respect to time produces the 
average liquid velocity (or volumetric flow rate if multiplied by the cross-sectional area of 
the microchannel). We have validated the exactness and repeatability of this 
measurement technique in several experiments (one example in Figure 5-3). The 
quantification of viscosity itself is discussed in detail in Power Law Index section. 
 
Figure 5-2 Rhoemeter design and physical principle: the position of the liquid column is 
identified by the shadow it casts on a photodiode. 
This technique has a number of critical advantages. First of all, the simplicity of the core 
devices means that the final product can be made durable, reliable, and portable while  
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still being affordable. Furthermore, because 
the signal is normalized during the signal 
processing, there is no need to calibrate the 
photodiode sensor or the light source. Even if 
the liquid is partially transparent, if some 
significant amount of light is blocked the 
device will function correctly. There is also no 
need to account for temperature variance 
effecting the power of the light source so long 
as it is not happening in the middle of the 
measurement. It also means that the 
microchannel itself does not need to have any micro-electro-mechanical system 
components in order to conduct the measurement. Therefore, the final microchannel 
cartridge can be extremely affordable to mass produce. The main drawback of this 
technique is the inability to detect liquids that are too transparent. To accommodate such 
liquids, we are currently developing a version of the device with dark-field microscopy 
principles which we have already validated will allow a single photodiode to detect 
transparent liquid traversal in a laboratory setting. 
5.3.1 Capillary Pressure inside the Microchannel Cartridge 
The pressure applied on the liquid column is one of several factors necessary to properly 
evaluate the viscosity of the travelling liquid, though it is the only one that cannot be 
evaluated before the measurement. The full viscosity measurement is very sensitive to 
changes in this pressure and this pressure must thus be accurately quantified during 
 
 
Figure 5-3 Single photodiode liquid 
column detection method agrees with 
digital image processing 
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every single viscosity measurement. We have chosen to use capillary pressure as the 
driving force of the measurement because it greatly reduces system complexity and 
removes the need to install, calibrate, and validate a pressure pump. Furthermore, 
capillary pressure quantification would be necessary even in the presence of a pressure 
pump since a non-negligible capillary effect would still be present in low viscosity liquids. 
The Young-Laplace equation describes mathematically the pressure experienced by the 
liquid (Δ𝑃) in terms of the liquid surface tension (𝜎), radius of curvature of the liquid 
surface inside the microchannel (𝑅1) and the radius of curvature of curvature of the droplet 
outside the microchannel (𝑅2) as 
Δ𝑃 = 𝜎(
1
𝑅1
+
1
𝑅2
) 
This expression [136] may simplify for certain liquids and particularly large droplets to 
Δ𝑃 = 𝜎 / 𝑅1 in the case that 𝑅2 ≫ 𝑅1. The capillary pressure can be further expressed in 
terms of the contact angle 𝜃, the microchannel height 𝑑, and the microchannel width 𝑤 
as 𝑃𝑐𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑦 = 2𝜎 cos(𝜃) (
1
𝑑
+
1
𝑤
) [137]. Since 𝑑 ≪ 𝑤 in a typical microchannel, this 
expression can be simplified to  
Δ𝑃 =
2𝜎 cos(𝜃)
𝑑
 
However, the surface and contact angle are specific to every liquid sample. It is not only 
impractical to measure both of these values before conducting a viscosity measurement 
but introduces further potential sources of error into the final capillary pressure 
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measurement. Instead, capillary pressure must be measured during the experiment and, 
because in some measurements 𝑅2 might still play an effect and change during the 
measurement, it must be measured and recorded continuously throughout the 
experiment. We note here that based on preliminary analysis other forces, such as the 
hydrostatic force of the liquid droplet, are negligible. 
Capillary Pressure itself can be measured through several techniques. For instance, the 
sample droplet can be exposed to a secondary microchannel of the same dimensions 
which is closed on the far end. As the sample enters and begins to traverse the 
microchannel, it will begin to compress the air inside. Eventually, the pressure of the 
compressed air will equal the capillary pressure and will stop the sample from moving 
forward. This air pressure, which equals the capillary pressure (𝑃𝑐𝑎𝑝𝑖𝑙𝑙𝑎𝑟𝑦) can be 
measured with a pressure sensor or by relating the new volume the air encompasses 
(𝑉𝑛𝑒𝑤) in the microchannel to the original microchannel volume (𝑉𝑜𝑟𝑔) with relation to the 
atmospheric pressure (𝑃𝑎𝑡𝑚) such that   𝑃𝑎𝑡𝑚𝑉𝑜𝑟𝑔 = (𝑃𝑎𝑡𝑚 + Δ𝑃)(𝑉𝑛𝑒𝑤) that is 
Δ𝑃 = 𝑃𝑎𝑡𝑚
𝑉𝑜𝑟𝑔
𝑉𝑛𝑒𝑤
− 𝑃𝑎𝑡𝑚 
Alternatively, the main channel can be blocked off with a valve, after the air has 
pressurized and a value is reached, the valve can be opened to continue the experiment. 
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5.3.2 The Power Law Index 
The principle of quantifying fluid viscosity based on microchannel traversal was described 
by Srivastava et al. in 2005 for Newtonian liquids [138] and 2006 for Non-Newtonian 
liquids [139]. For non-Newtonian liquids, the aforementioned method used a Hagen-
Poiseuille flow equation modified to conform to a Power Law Fluid. Power Law Fluids are 
idealized models used to describe real liquids. The expressions the authors developed 
are 
1
𝐿(𝑡)
= 𝐶𝑣(𝑡)𝑛 
𝜂(𝑡) =
𝑑2
𝑆
1
(
2
3 +
1
3𝑛)
Δ𝑃
𝑣(𝑡)𝐿(𝑡)
  
Where 𝑛 is the power law index which describes the change in viscosity with respect to 
shear rate, 𝐿(𝑡) is the liquid column length, 𝑣(𝑡) is the liquid column mean velocity (which 
is directly proportional with volumetric flow rate), 𝜂(𝑡) is the viscosity, 𝑑 is the thickness 
of the microchannel, 𝑆 is a constant factor characterizing the geometry, 𝐶 is a constant 
dependent on the power law index, and Δ𝑃 is the pressure applied on the microchannel. 
As expected, this expression simplifies to the Hagen-Poiseuille flow equation when 𝑛 =
1, which is a Newtonian liquid described by the power law. If the power law index 𝑛 is 
constant, it is possible to curve-fit the first expression in order to quantify 𝑛.  
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We note here that a constant value of 𝑛 does not describe many liquids correctly. Applying 
the aforementioned expression directly and conforming to the assumption that 𝑛 is 
constant can produce erroneous viscosity results. Based on preliminary data we have 
found the value of the power law index depends on shear rate. Future work may develop 
an algorithm to identify the values of 𝑛 of the liquid continuously throughout the 
measurement. 
However, in the cases that the power law exponent 𝑛 is, in fact, constant, the expression 
1
𝐿(𝑡)
= 𝐶𝑣(𝑡)𝑛 is an ordinary differential equation which may be solved as  
𝐿(𝑡) = [(𝑡 + 𝑡0) (
𝑛 + 1
𝑛
) (
1
𝐶
)
1
𝑛
 ]
𝑛
𝑛+1
 
Where 𝑡0 is a constant that is 𝑡0 = 0 if the measurement begins at 𝑡 = 0. This expression 
can be curve-fit to the data of the liquid column length with respect to time to find the 
value of 𝑛. 
5.3.3 Shear-Rate Range 
The Shear-Rate applied to the liquid is dependent on how far into the channel it has 
pervaded. The wall shear rate can be evaluated as  
?̇?𝑤 =
6𝑄(𝑡)
𝑤𝑑2
[
2
3
+
1
3𝑛
] 
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Where 𝑄(𝑡) is the volumetric flow rate and the other parameters are as described in the 
Power Law Index section [139]. We note that the Hagen-Poiseuille flow equation is known 
to fail in particularly short pipes due to the molecular limitations in liquids that are not 
accounted for in the equation. In our case this is analogous to a sample first entering the 
microchannel. 
5.4 Results 
We have created a preliminary stationary prototype using premanufactured components 
in order to demonstrate the feasibility of the sensor. This device (Figure 5-4) has 
demonstrated the feasibility of tracking liquid traversal through a microchannel. The 
 
Figure 5-4 A Early prototype featuring core device components B. Microfluidic cartridges 
comprised of glass and specialized hydrophilic microfluidic polyester films. C. Preliminary 
viscosity data of black ink (top) and shoe shine (bottom). 
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prototype features the vital working components that will comprise the final core device. 
Using this $1,500 prototype, we have collected preliminary viscosity measurements of a 
black ink and a shoe shine and corroborated the measurements using a $70,000 
industrial rheometer (AR G2 Magnetic Bearing Rheometer by TA Instruments). These 
preliminary measurements were done by estimating capillary pressure, manually 
managing the curve-fit of the data to find the power law index of the liquid sample, and 
manually eliminating the potentially erroneous shear rate range of the measurement. This 
prototype was created in order to minimize the time required to collect meaningful result 
using the physical principles we wish to exploit. A number of parameters still need to be 
accounted for with greater fidelity using additional sensors, most notably the exact value 
of the capillary pressure must be recorded with greater precision. Future work may also 
include the application of dark field microscopy principles to the set up in order to 
accurately track transparent liquids. 
Our microfluidic cartridges are comprised of two constantly hydrophilic microchannels. 
The cartridge is comprised of a glass slide, a central polyester layer which has been cut 
to the dimensions of a desired microchannel, and a transparent polyester layer of which 
has been laser cut to provide inlet and outlet ports for the device and give a hydrophilic 
coating. None of the three materials are air permeable, which is an important factor in 
several potential techniques of determining the capillary pressure experienced by the 
liquid. Both of the polyester films already have FDA approval and a number of medical 
conversion companies use them to mass produce microfluidic devices. 
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We have developed a functional circuit 
board outfitted with a photodiode, a 
pressure sensor, and external input 
and output to communicate with a 
personal commuter (Figure 5-5). The 
circuit board records the amount of 
light collected by the photodiode and 
the pressure experienced by the 
pressure sensor and streams the 
information through a USB connection at up to 10,000 Hz. The streamed data is 
processed by MATLAB and LabView codes to convert the results into viscosity 
measurements. This circuit board may be integrated into a second portable version of the 
prototype in Future Work. The second prototype will act as the main tool in the 
development of solutions for the associated technological challenges of quantifying the 
capillary pressure, the sample’s power law index, and the working shear rate range.  
 
Figure 5-6 Viscosity measurements for 
the same sample (black ink) are 
consistent, varying approximately 20%. 
This results assumes a consistent 
capillary pressure, a consistent manual 
selection of an appropriate constant factor 
characterizing the microchannel, and 
assumes that the power law exponent is 
constant. The appropriate shear rate 
range was also manually selected and 
results at either extreme were discard. 
 
Figure 5-5 Printed circuit board for our next 
prototype design and experimental setup. 
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6.1 Introduction 
Intuition, conjecture, and experimentation are essential driving forces behind innovation 
and scientific discovery. These principles may be intrinsically augmented thanks to the 
appearance of immersive virtual reality in the public eye. The success of this tool 
invariably forces us to inquire into the fundamental nature of how we perceive and interact 
with the world around us. Within this framework, interactive simulations in a virtual reality 
(VR) environment border on becoming virtual experiments conducted by the researcher. 
Interactive simulation has already been used in surgical simulations to train medical 
professionals in place of cadavers or animals [84, 85], to assist and save cost in parts 
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design [86], and even in flood threat analysis [87]. Furthermore, the development of any 
one simulation benefits directly from a design philosophy that integrates constant 
visualization and interactivity [88]. The use of contemporary virtual reality enables swift 
and intuitive detection of errors and conflicts between simulation parameters and reality. 
Virtual reality in general has enjoyed an enthusiastic academic and commercial 
community of developers for a number of decades. Numerous attempts at immersion in 
a virtual world have been explored with varying degrees of success in that time. The early 
1990’s saw a rise in public interest in VR with the developments of a number of VR 
systems such as the CAVE system [89], a cubic room of screens meant to immerse 
multiple users, though the system suffered from its cumbersome size and high price-tag, 
PowerWalls and its derivatives [90], arrays of screens or very large screens such as the 
ImmersaDesk and Inifinity Wall, and commercial attempts at releasing low resolution 
head-mounted displays (HMDs). These tools were studied for their effectiveness in 
various applications, such as the delivery of exposure therapy, though the associated 
technological challenges proved too cumbersome for the time [91].  
Despite public focus leaving VR, development and enhancement of the technology 
continued steadily. Over the last five years, HMDs have breached public discourse on a 
massive scale once again thanks to technological advancements that provide 
unprecedented visual fidelity packaged with affordability. These advancements include 
high-refresh rate, high resolution, and low-persistence displays, fast and accurate motion 
tracking, and personal computers capable of continuously rendering graphically 
impressive virtual worlds. As a result of this high visual fidelity, the best modern HMDs 
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(e.g. HTC Vive, Oculus Rift) provide users with a superior sense of presence, a self-
reported quality of “being there” [92]. Modern HMDs, which became available for 
application development in 2013 and to the public commercially in 2016, have 
experienced relative commercial success in entertainment and, concurrently, a number 
of VR-centric studies have reported success in a varied assortment of clinical applications 
[91, 93-97]. Modern HMDs provide the academic community at large the opportunity to 
utilize VR in applications that were previously unattainable. The standardized interface 
code that is now employed commercially ensures that VR applications will remain 
compatible with upcoming HMDs.  
One simulation technique that can considerably benefit from integration with modern 
HMDs is molecular dynamics (MD). Virtual reality provides an immersive experience that 
can bestow a deep intuitive understanding of the molecular interactions and their effect 
on the emergent system. Without the use of modern HMDs such an intuitive 
understanding of MD simulations is challenging to acquire even with the aid of 
contemporary visualization tools, such as VMD [98]. Interactivity with simulations during 
run-time is certainly possible in programs such as VMD but the associated screen-based 
interfaces, traditional input controllers (e.g. mouse and keyboard), and classical VR 
systems often complicate three-dimensional interactions and exploration to the point of 
impracticality. Integration of MD with modern HMDs will allow researchers to intuitively 
perturb and interact with their simulations in VR by applying external forces, steering 
components, and by causing shape changes.  
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Visualization of volumetric images, as those produced by techniques such as confocal 
microscopy, super-resolution microscopy [99], magnetic resonance imaging, and cryo-
electron microscopy [100] has long suffered due to the underlying complication of having 
to display innately three-dimensional images on incompatible two-dimensional monitors. 
Even three dimensional anaglyph stereoscopy is used in order to ease the difficult 
interpretation of volumetric data [101, 102]. Similar to its application in MD in this regard, 
virtual reality offers a natural and compatible way to reconstruct and explore volumetric 
images and simulations by invoking them in a three-dimensional environment. A number 
of academic and commercial packages, such as UCSF ChimeraX [103] and VMD, 
currently provide shape rendering in both classic and contemporary VR systems, and 
integration with classic VR systems has been available since their inception. These tools 
use algorithms that attempt to display a solid shape meant to represent the scanned 
object, commonly referred to as an “iso-surface.” However, such algorithms may 
significantly distort particular volumetric maps, especially those that display gradients, 
subtle effects, or “soft boundaries.” Sculptor [104], a notable open-source visualization 
package, provides users with a direct volume rendering technique in order to render 
gradients or “soft boundaries” [105] and even integrates with classic VR systems. 
However, the software is not currently directly compatible with modern HMDs. 
The recent technological breakthroughs in HMD technology in the last five years have 
paved the way for us to undertake these challenges to integrate the visual fidelity, coding 
standards, and affordability of modern HMDs with (1) manual and immersive three-
dimensional particle steering during simulation run-time and with (2) undistorted 
volumetric rendering of static volumetric maps such as those produced by confocal 
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microscopy. We have developed an interactive multiphysics simulation and visualization 
environment in virtual reality called Interactive MultiPhysics EnvironmenT for Unified 
Simulation in Virtual Reality (IMPETUS-VR). Using this tool, researchers will be able to 
experience and manually interact with their simulations and steer individual components 
during runtime. IMPETUS-VR offers researchers interactive VR integrated particle-based 
simulations that interact with and run in parallel with gradient continuum field simulations 
and long-range force network simulations. Additionally, they will be able to literally walk 
through the data and explore any static volumetric image (defined by cross-sectional 
volumetric maps) in the very same three-dimensions inherent in their image while 
maintaining the integrity of the image. The fundamental dimensional agreement between 
the simulation or image space and the visualization space grants ineffable understanding 
of the simulation or image details and allows the researcher to exert immediate control 
over their work. The dimensional agreement also allows researchers to not only instantly 
select any desired perspective, including inside the simulation itself, but to observe and 
interact with previously unobservable blind spots that could not be accessed through two-
dimensional representations.  
6.2 Design and Implementation 
Simulations in IMPETUS-VR are powered by the Interactive MultiPhysics EnvironmenT 
for Unified Simulation (IMPETUS) [106] which is a powerful C++ based, object oriented 
simulation engine. IMPETUS is capable of simultaneous and interdependent evaluation 
of continuum models, long-range particle networks, and short-range particle interactions. 
This code is available independently, with associated tutorials, online. All IMPETUS 
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functionality has been fully implemented in IMPETUS-VR. Thus, users can create and 
visualize simulations using the IMPETUS libraries, or even import molecular dynamics 
configurational files, such as .cfg, in order to view them in virtual reality. They can also 
employ the code structure that we have provided with IMPETUS-VR, which is based on 
Unreal Engine 4, as a foundation for implementing their preferred MD simulation code. 
The demonstration video of IMPETUS-VR (Supplementary Video 1) illustrates the general 
functional principles of the software and some of its practical applications.  
6.2.1 Code Structure 
This environment was made possible by integrating a serialized version of the Interactive 
Multi-Physics EnvironmenT for Unified Simulations (IMPETUS) [106] with the Unreal 
Engine 4. We chose Unreal Engine 4 because it offers openly available source code. In 
IMPETUS-VR the Unreal Engine 4 software is responsible for the interactivity and the 
visualization of the simulation state: the software renders the state and handles user 
interactions and commands. In turn, IMPETUS processes the simulation in a separate 
thread, a technique known as multithreading, which functions on the principle of 
evaluating multiple processes concurrently. This means that as each visualization frame 
is rendered for display any spare computational power is allocated to the numerical 
computation of the simulation. The structure of the code can be seen in Figure 6-1. 
Throughout the course of simulation development in virtual reality, we have found that an 
inconsistent or jarring frame rate is difficult to observe at best and nauseating at worst. 
Multithreading empowers IMPETUS-VR to maintain an adequate visualization frame rate 
at the cost of potentially slowing down the computation time of particularly large 
simulations. 
 83 
 
 
Figure 6-1. IMPETUS-VR connects the Modular Interactive Domains (MIDs) of 
IMPETUS to the Unreal Engine. These domains are currently the Particle Dynamics 
domain, Interactive Finite Difference domain and the Network domain. Unreal Engine 
4 renders and presents the scene to the user through the HTC Vive. The Vive 
controllers allow users to directly interact with and influence the simulations.  
6.2.2 Volumetric Visualization Algorithm 
We implemented the visualization of volumetric three-dimensional microscopy images 
following a heuristic approach where every cross-section of the image is displayed as an 
individual image separated in the normal direction from adjacent cross-sections. Each 
slice is partially transparent such that the transparency of every pixel is linearly inversely 
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proportional to its brightness. The method is demonstrated in Figure 6-2. This 
implementation of volumetric representation produces little computational overhead 
without sacrificing the fidelity of the source image. Volume rendering algorithms that also  
 
Figure 6-2. Algorithm for volumetric representation of a 3D confocal microscopy image 
via IMPETUS-VR. (A,B) The fluorescent channel of the z-stack of the images recorded 
through a confocal microscope (A) are combined to produce a full-color image for each 
slice (Bii). B(i-iii) are sampled slices in the z-stack generated as explained above. (C) 
These slices are then loaded in IMPETUS-VR in an ordered manner and made partially 
transparent on a pixel-by-pixel basis such that dark pixels are more transparent than 
bright pixels. (D)The individual images are then placed in a three-dimensional space on 
top of one another and presented to the viewer as a full volumetric image. 
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preserve image integrity, such as volume ray casting or three-dimensional texturing, are 
too computationally taxing, and thus preclude the use of modern HMDs. Conversely, 
algorithms, such as the shear warp algorithm [107]  or splatting [108], which are 
sufficiently inexpensive to render in virtual reality degrade image quality and often 
misrepresent the acquired data. This is due to the algorithm’s core goal to represent the 
volumetric object as a solid shape with a well-defined boundary. The conversion from 
volumetric map to solid object may significantly distort the original cross-sectional 
volumetric maps especially when gradients, subtle effects, or “soft boundaries” are 
present in the map. These and similar algorithms are currently the most popular methods 
of volumetric visualization of the majority of modern VR applications. 
6.2.3 Computer Specifications 
IMPETUS-VR was tested with the HTC Vive on a custom built computer running Windows 
10 (Intel® Core™ i7-5820K CPU @ 3.30GHz, Radeon RX480 graphics card, 16GB of 
RAM, and MSI X99A Raider motherboard) and visualized more than 15,000 individual 
low polygon count spheres or more than 65,000 individual cubes without a frame rate 
drop in virtual reality. The number of seamlessly rendered simulation components is a 
hardware limitation that will improve with the release of superior hardware.  
6.3 Ethics Statement 
The individual in this manuscript (Supplementary Video 1) has given written informed 
consent to publish these case details. 
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6.4 Results 
In order to highlight the capabilities of IMPETUS-VR we have produced a number of fully 
interactive simulations that users may modify by using a personal virtual reality head 
mounted display and associated controllers. Specifically, we have developed a solvent-
free model of a phospholipid bilayer (Figure 6-3A, Supplementary Vid. 2)  [109], and a 
simulation of a spectrin network which corresponds to the cytoskeleton connected to the 
red blood cell membrane (Figure 6-3B) [110]. The specific models are discussed in detail 
in [109] and [110] respectively. These simulations demonstrate the ability to explore 
interactively the properties of emergent systems as they are perturbed and rearranged in 
virtual reality. Furthermore, using IMPETUS-VR, we modeled the interaction between 
cranial neural crest and cranial placode cells during collective cell migration 
(Supplementary Figure 6-2A, Supplementary Vid 3) to reproduce experimental results 
produced in Theveneau, E. et al. [111]. This simulation is an example of a continuum field 
whose gradient is visualized as green vectors with orientations and magnitudes that are 
explicitly apparent in virtual reality. This clarity is not practically achievable outside of the 
realm of VR. We have further produced an exemplary simulation of a network of particles 
that interact via long-range spring forces while at the same time are subjected to the 
Lennard-Jones potential and to the Nose-Hoover thermostat (Supplementary Figure 6-
2B, Supplementary Vid 4). This simulation demonstrates the visualization of long-range 
forces as “tethers” within virtual reality. We note that these simulations are described in 
greater detail in their original non-interactive non-VR states in the IMPETUS publication 
[106]. Similar manual particle steering during simulation run-time applications have 
historically been available in classic VR systems, such as VMD. However, these tools 
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lack integration with modern HMDs and are generally meant as two-dimensional “on-
screen” applications. As a result, their practical usability suffers in terms of affordability 
and three-dimensional freedom of movement, especially when manual steering and view 
selection requires the use of mouse and keyboard, which physically restrict user inputs 
to two dimensions. 
 
Figure 6-3. Exemplary simulations provided with IMPETUS-VR. A. A simulation of a 
solvent-free model of a phospholipid bilayer where each blue shape represents a 
cluster of lipids, while the red and yellow shapes represent arbitrary membrane 
proteins. B. A spectrin network which corresponds to the cytoskeleton connected to the 
red blood cell membrane. The red particles represent actin junctions and the green 
particles represent spectrin chain repeats. 
We note here that we have developed a number of user controls meant to improve the 
user experience. We implemented simple “floating menus” in order to allow users to 
navigate the software while using the HMD itself. These menus are inspired by similar 
menu options seen in modern VR entertainment applications. Our experience with the 
IMPETUS-VR environment has shown that floating menus, which make the use of 
keyboard and mouse unnecessary, greatly improve practical usability of the virtual 
environment as well as suggest enhancement of the sensation of presence (the self-
reported quality of “being there”). Another feature developed with the user in mind are the 
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exploration controls which we designed to minimize the potential for “virtual reality 
sickness” (also known as “cyber sickness” or simply “motion sickness”) [112]. In 
IMPETUS-VR, users directly control the rotation and position of the visualized object 
itself, rather than their own virtual position. These controls are intended to promote a 
sense of control over the visualized object while maintaining the stability of the viewer in 
the virtual world.  
To further showcase the abilities of IMPETUS-VR in terms of volumetric visualization, we 
have provided a number of volumetrically rendered confocal microscopy images. A 102 
µm by 102 µm by 19 µm confocal microscopy image of a kidney mouse section can be 
seen in IMPETUS-VR (Figure 6-5A, Supplementary Vid 5). The three-dimensional 
structure of the mouse kidney section can be partially inferred in the figure itself, however 
it is self-evident when viewed in three dimensions. We have also included a confocal scan 
of ICAM4 expressed on the surface of a Sickle Red Blood Cell (Figure 6-4). We note that 
the integrity and clarity of gradients and subtle effects visible in the individual cross-
sections of the volumetric maps remain observable in final volumetric render. However, 
this particular method prevents users from changing image channel representations (i.e. 
individual colors meant to identify different components of the volumetric map) in real-
time due to the way each individual cross-section is represented. This is a fundamental 
limitation of the technique itself, and although a menu and tools can be added to allow 
users to adjust channel intensities in real-time the response would likely be too slow using 
modern personal computers to be considered practical. Another limitation comes from the 
fact that the render is not comprehensible when viewed exactly from the side, where the 
individual layers appear to have no thickness. We note that these limitations can be 
 89 
 
overcome with the use of certain established direct volume rendering techniques, such 
as those used by Sculptor [105], though these and similar algorithms may be too 
computationally taxing for high resolution volumetric maps to be used in current HMDs. 
The preceding figures and others are available as 360 panoramas and can be viewed 
online through your browser, cell phone, or personal virtual reality headset 
(http://www.engr.uconn.edu/~gelyko/impetusvr.html). We have also made the program 
code (under the GNU General Public License version 3) and associated libraries, the 
demonstration video, a user manual, and a tutorial video available online at the same web 
address. 
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Figure 6-4 Volumetric representation of a three-dimensional confocal microscopy 
image of a sickle-cell red blood cell (SS-RBC). The green color represents ICAM4 
receptors expressed on the surface of a red blood cell while the red color represents 
𝛼𝑣𝛽3 protein that is adherent to the SS-RBC surface. Data courtesy of Dr. Krithika 
Abiraman, reproduced here with her permission. 
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Figure 6-5. Volumetric representations of three-dimensional confocal microscopy 
images. A. A 102 μm x 102 µm x 19 µm volumetric image of a kidney mouse section. 
Here the blue color represents actin, the green color represents wheat germ agglutinin 
(a general stain for the surfaces of cells), and the red color represents the nuclei. B. A 
290 µm x 290 µm x 20 µm scan of a hippocampus section where the red color 
represents cell nuclei stained with DAPI and the green color represents activated glial 
cells stained with GFAP.  
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6.5 Supplementary Information 
 
Supplementary Figure 6-S1. An IMPETUS-VR render of exemplary simulations. A. 
The interaction between cranial neural crests (represented by blue particles) and cranial 
placode cells (represented by red particles) during collective cell migration as it viewed 
by the user inside the head mounted display. The green arrows represent the three-
dimensional gradient field of the chemoattractant produced by the placode cells. The 
nature of the gradient field is clearly apparent in virtual reality. B. A simulation 
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highlighting the representation of the network of long-range particle interactions 
displayed as red “tethers.” 
Supplementary Videos 1 through 5 can be found online at 
http://www.engr.uconn.edu/~gelyko/impetusvr.html 
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Chapter 7: Epilogue 
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We have worked to expedite the acquisition of results, whether simulation or 
experimental, and to increase the throughput of measurements in studies which utilize 
atomic force microscopy, explore cell adhesion to specific proteins, in simulations which 
explore cell mechanics, and in rheological measurements. Overall we have explored 
several techniques to accomplish this, namely automated data processing, virtual reality, 
and microfluidics. These methods provide the possibility of accelerating the acquisition of 
sound experimental and simulation data. 
Data analysis of force spectroscopy curves from atomic force microscopy has historically 
been a very time-consuming and tedious endeavor. Researchers can spend several 
hours processing the results from just several. To alleviate this massive time waste we 
developed FRAME. Our software offers a directly applicable array of modifiable tools to 
AFM users for expediting data processing. FRAME algorithms process AFM data 
extremely quickly compared to the time required for manual processing. 1024 curves are 
processed in less than one minute for unbinding events and in less than five minutes for 
Young's modulus measurements in a typical work station. FRAME also provides 
convenient manual processing tools that are integrated with automated processing. 
FRAME can automatically import force-displacement curves from AFMs by Asylum 
Research (.ibw files). Users of other brands of AFMs can import force-displacement 
measurements formatted as delimited text files into FRAME following instructions in the 
User's Manual.  
Early versions of FRAME developed out of our exploration of Single Cell Force 
Spectroscopy where the need for increased processing speed was readily apparent. We 
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used the original functions and GUI-free environment to established SCFS as a method 
in quantifying the adhesion of RBCs to functionalized substrates. This method allowed us 
to explore the modulation of RBC adhesion via physiological reagents, such as 
epinephrine, by affecting the cAMP-PKA pathway. 
We needed to explore the adhesive and mechanical properties of a larger number of 
RBCs at one time because the data may be too variable for 5 cells to describe the 
properties of the population in a meaningful way. To meet this need, we produced a high-
throughput microfluidics testing setup. This experimental setup presents an opportunity 
to quickly and precisely quantify the mechanical and pharmacological properties of SS-
RBCs in many different assays. This is enabled by the combination of equipment, 
specifically the high-speed camera and the precise and instantly modifiable pressure flow, 
the surface functionalization protocol, and custom image processing software. Minor 
tweaks to the assay parameters, such as the concentration of endothelial protein during 
functionalization, may also be appropriate to maximize the sensitivity of the system and 
elucidate SS-RBC properties. The current setup can be easily modified to enable 
experiments under controlled oxygen levels.  
The experimental methods above may potentially also be conducted in similar assays on 
wildtype RBCs or in efforts to study other related diseases, such as malaria or diabetes, 
where either RBC adhesion or mechanical behavior plays a major role in pathology. The 
same advantages and improvements presented in this report may prove to be applicable 
is such studies. Thus, this potential is an avenue for future work in this area.  
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Current solutions for measuring whole blood viscosity are not practical for the application: 
tests are slow, require a lot of blood and sterilization, and the associated equipment is 
complex and not portable. We have endeavored to enable simple and accessible whole 
blood viscosity measurements by designing and developing our own microfluidics based 
rheometer. Our assembly for measuring the viscosity of various liquids through the use 
of microchannels provides a promising improvement in currently available rheometers. 
Several key features, such as fast measurements, small sample size, and lack of 
sterilization may produce a device which enables regular whole blood viscosity 
measurements even at the point of care. This measurement is important in hyperviscosity 
syndrome, a condition which may arise in certain illnesses such as Waldenström’s 
Macroglobulinemia. Whole blood viscosity may also be important in monitoring overall 
cardiovascular health. 
We have produced IMPETUS-VR to create truly interactive three-dimensional simulations 
and an intuitive three-dimensional data visualization environment. This tool greatly 
improves the fidelity, development, and understanding of IMPETUS simulations. 
Furthermore, it provides researchers a method of visualizing their three-dimensional data 
in three-dimensions, instead of distorting it into two-dimensions. 
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Publications 
Journal Publications and Patent Filings 
K.PARTOLA, G. LYKOTRAFITIS, Pending US and PCT Patent App. 15/970,226 
“Assembly for Measuring the Viscosity of Fluids Using Microchannels” 2018 
K. PARTOLA, B. ANDEMARIAM (MD) and G. LYKOTRAFITIS 'Microfluidic Experimental 
Setup for Adhesion and Recovery Measurements of Red Blood Cells in Sickle Cell 
Disease', Journal of the Mechanical Behavior of Biomedical Materials, 71, 80-84, 2017  
K. PARTOLA and G. LYKOTRAFITIS, 'FRAME (Force Review Automation Environment): 
MATLAB-based AFM data processor', Journal of Biomechanics, 49, Issue 7, 1221-1224 
2016 
J. MACIASZEK, K. PARTOLA, J. ZHANG, B. ANDEMARIAM (MD), and G. 
LYKOTRAFITIS, 'Single-cell force spectroscopy as a technique to quantify human red 
blood cell adhesion to subendothelial laminin', Journal of Biomechanics, 47, Issue 16, 
3855-3861, 2014 
Conference Proceedings 
K. PARTOLA, J. ZHANG, S. JONES, G. LYKOTRAFITIS, B. ANDEMARIAM, ‘Valsartan 
Attenuates Epinephrine-stimulated ICAM-4 Activation on Normal, Sickle Cell Trait and 
Sickle Cell Disease Red Blood Cells,’ 18th U.S. National Congress for Theoretical and 
Applied Mechanics June 4-9, 2018 
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